EP3986874A1 - Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques - Google Patents

Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques

Info

Publication number
EP3986874A1
EP3986874A1 EP20734145.4A EP20734145A EP3986874A1 EP 3986874 A1 EP3986874 A1 EP 3986874A1 EP 20734145 A EP20734145 A EP 20734145A EP 3986874 A1 EP3986874 A1 EP 3986874A1
Authority
EP
European Patent Office
Prior art keywords
alkyl
group
cycloalkyl
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20734145.4A
Other languages
German (de)
English (en)
Inventor
Anne-Sophie Rebstock
Philippe Desbordes
Jeremy Dufour
Pierre-Yves Coqueron
Sebastien Naud
Pierre Genix
Vincent Thomas
Sophie DUCERF
Aurelie MALLINGER
Jacopo NEGRONI
Andreas GÖRTZ
Christoph Andreas Braun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of EP3986874A1 publication Critical patent/EP3986874A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/84—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Definitions

  • the present invention relates to the use of hydroxyisoxazolines and derivatives thereof as fungicides. It also relates to new hydroxyisoxazolines derivatives, their use as fungicides and compositions comprising thereof.
  • Isoxazole derivatives are known to be useful as crop protection agents to combat or prevent microorganisms’ infestations.
  • WO2015/129773 discloses isoxazole derivatives that may be used as fungicides.
  • W02006/031631 discloses substituted isoxazoles that may be used for the control of microbial pests, particularly fungal pests, on plants.
  • hydroxyisoxazole derivatives are far less common and seldomly used for the control of microbial pests.
  • W099/05130 and WO2018/006561 disclose hydroxyisoxazole derivatives that may be used for treatment of many human diseases. More recently, hydroxy-isoxazoles were disclosed as useful for controlling phytopathogenic fungi (WO2018/202487).
  • fungicidal agents Numerous fungicidal agents have been developed until now. However, the need remains for the development of new fungicidal compounds in order to address the ever increasing environmental and economic requirements imposed on modern-day crop protection agents and compositions. This includes, for example, improvement to the spectrum of action, safety profile, selectivity, application rate, formation of residues, and favourable preparation ability. It may also be desired to have new compounds to prevent the emergence of fungicides resistances.
  • the present invention provides new fungicidal compounds which have advantages over known compounds and compositions in at least some of these aspects.
  • the present invention relates to compounds of the formula (I):
  • X, Y, R 1 , R 2 , L, m, n and A are as recited herein as well as their salts, N-oxides, solvates, stereoisomers and any stereoisomers mixtures.
  • the present invention relates to a composition
  • a composition comprising at least one compound of formula (I) as defined herein and at least one agriculturally suitable auxiliary.
  • the present invention also relates to the use of a compound of formula (I) as defined herein or a composition as defined herein for controlling phytopathogenic fungi.
  • the present invention relates to a method for controlling phytopathogenic fungi which comprises the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to the plants, plant parts, seeds, fruits or to the soil in which the plants grow.
  • halogen refers to fluorine, chlorine, bromine or iodine atom.
  • oxo refers to an oxygen atom which is bound to a carbon atom or sulfur atom via a double bound.
  • Ci-Cs-alkyl refers to a saturated, branched or straight hydrocarbon chain having 1 , 2, 3, 4, 5, 6, 7 or 8 carbon atoms.
  • Examples of Ci-Cs-alkyl include but are not limited to methyl, ethyl, propyl (n-propyl), 1 -methylethyl (iso-propyl), butyl (n-butyl), 1 -methylpropyl (sec-butyl), 2-methylpropyl (iso-butyl), 1 ,1 -dimethylethyl (fe/ -butyl), pentyl, 1 -methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1 -ethylpropyl, 1 ,1 -dimethylpropyl, 1 ,2-dimethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpent
  • said hydrocarbon chain has 1 , 2, 3 or 4 carbon atoms (“Ci-C 4 -alkyl”), e.g. methyl, ethyl, propyl, iso-propyl, butyl, sec-butyl, isobutyl or fe/ -butyl.
  • Ci-C 4 -alkyl e.g. methyl, ethyl, propyl, iso-propyl, butyl, sec-butyl, isobutyl or fe/ -butyl.
  • C2-C8-alkenyl refers to an unsaturated, branched or straight hydrocarbon chain having 2, 3, 4, 5, 6, 7 or 8 carbon atoms and comprising at least one double bond.
  • Examples of C2-C8- alkenyl include but are not limited to ethenyl (or "vinyl"), prop-2-en-1 -yl (or “allyl”), prop-1 -en-1 -yl, but-3- enyl, but-2-enyl, but-1 -enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1 -enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1 -enyl, prop-1 -en-2-yl (or “isopropenyl”), 2-methylprop-2-enyl, 1 -methylprop-
  • C2-C8-alkynyl refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5, 6, 7 or 8 carbon atoms and comprising at least one triple bond.
  • Examples of C2-C8-alkynyl include but are not limited to ethynyl, prop-1 -ynyl, prop-2-ynyl (or “propargyl"), but-1 -ynyl, but-2-ynyl, but-3-ynyl, pent-1 -ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1 -ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5- ynyl, 1 -methylprop-2-ynyl, 2-methylbut-3-ynyl, 1 -methylbut-3-ynyl, 1 -
  • Ci-Cs-halogenoalkyl refers to a Ci-Cs-alkyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-halogenoalkyl comprises up to 9 halogen atoms that can be the same or different.
  • C2-C8-halogenoalkenyl refers to a C2-Cs-alkenyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-halogenoalkenyl comprises up to 9 halogen atoms that can be the same or different.
  • C2-C8-halogenoalkynyl refers to a C2-Cs-alkynyl group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-halogenoalkynyl comprises up to 9 halogen atoms that can be the same or different.
  • Ci-Cs-alkoxy refers to a group of formula (Ci-C8-alkyl)-0-, in which the term "Ci-Cs-alkyl” is as defined herein.
  • Examples of Ci-Cs-alkoxy include but are not limited to methoxy, ethoxy, n-propoxy, 1 -methylethoxy, n-butoxy, 1 -methylpropoxy, 2-methylpropoxy, 1 ,1 -dimethylethoxy, n-pentoxy, 1 -methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1 -ethylpropoxy, 1 ,1 - dimethylpropoxy, 1 ,2-dimethylpropoxy, n-hexyloxy, 1 -methylpentoxy, 2-methylpentoxy, 3-methylpentoxy,
  • Ci-Cs-halogenoalkoxy refers to a Ci-Cs-alkoxy group as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-halogenoalkoxy examples include but are not limited to chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1 -chloroethoxy, 1 -bromoethoxy, 1 - fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro- 2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1 ,1 ,1 - trifluoroprop-2-oxy.
  • Ci-Cs-alkylsulfanyl refers to a saturated, linear or branched group of formula (Ci-C8-alkyl)-S-, in which the term “Ci-Cs-alkyl” is as defined herein.
  • Ci-Cs-alkylsulfanyl examples include but are not limited to methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, sec-butylsulfanyl, isobutylsulfanyl, fe/ -butylsulfanyl, pentylsulfanyl, isopentylsulfanyl, hexylsulfanyl group.
  • Ci-Cs-halogenoalkylsulfanyl refers to a Ci-Cs-alkylsulfanyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-alkylsulfinyl examples include but are not limited to saturated, straight-chain or branched alkylsulfinyl radicals having 1 to 8, preferably 1 to 6 and more preferably 1 to 4 carbon atoms, for example (but not limited to) methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1 -methylethylsulfinyl, butylsulfinyl, 1 -methylpropylsulfinyl, 2- methylpropylsulfinyl, 1 ,1 -dimethylethylsulfinyl, pentylsulfinyl, 1 -methylbutylsulfinyl, 2-methylbutylsulfinyl,
  • Ci-Cs-halogenoalkylsulfinyl refers to a Ci-Cs-alkylsulfinyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-alkylsulfonyl examples include but are not limited to methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1 -methylethylsulfonyl, butylsulfonyl, 1 -methylpropylsulfonyl, 2-methylpropylsulfonyl, 1 ,1 -dimethylethylsulfonyl, pentylsulfonyl, 1 - methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1 - ethylpropylsulfonyl, 1 ,1 -dimethylpropylsulfonyl, 1 ,2-dimethylpropylsulfonyl, hexylsulfonyl,
  • Ci-Cs-halogenoalkylsulfonyl refers to a Ci-Cs-alkylsulfonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-halogenoalkylcarbonyl refers to a Ci-Cs-alkylcarbonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • Ci-Cs-haloalkoxycarbonyl refers to a Ci-Cs-alkoxycarbonyl as defined above in which one or more hydrogen atoms are replaced with one or more halogen atoms that may be the same or different.
  • non-aromatic C3-Ci 2 -carbocycle refers to a non-aromatic, saturated or partially unsaturated, hydrocarbon ring system in which all of the ring members, which vary from 3 to 12, are carbon atoms.
  • the ring system may be monocyclic or polycyclic (fused, spiro or bridged).
  • Non-aromatic C3-C12- carbocycles include but are not limited to C3-Ci 2 -cycloalkyl (mono or bicyclic), C3-Ci 2 -cycloalkenyl (mono or bicyclic), bicylic system comprising an aryl (e.g.
  • phenyl fused to a monocyclic C3-C7-cycloalkyl (e.g. tetrahydronaphthalenyl, indanyl), bicylic system comprising an aryl (e.g. phenyl) fused to a monocyclic C3- Ce-cycloalkenyl (e.g. indenyl, dihydronaphthalenyl) and tricyclic system comprising a cyclopropyl connected through one carbon atom to a bicylic system comprising an aryl (e.g. phenyl) fused to a monocyclic C3-C7-cycloalkyl or to a monocyclic C3-C8-cycloalkenyl.
  • the non-aromatic C3-Ci 2 -carbocycle can be attached to the parent molecular moiety through any carbon atom.
  • C3-Ci 2 -cycloalkyl refers to a saturated, monovalent, mono- or bicylic hydrocarbon ring which contains 3, 4, 5, 6, 7, 8, 9, 10, 1 1 or 12 carbon atoms.“C3-C7-cycloalkyl” as used herein designates monocyclic C3-C7-cycloalkyls which include but are not limited to cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, cycloheptyl.
  • bicyclic C6-Ci2-cycloalkyls include but are not limited to bicyclo[3.1 .1 Jheptane, bicyclo[2.2.1 Jheptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, bicyclo[3.3.1 Jnonane, bicyclo[4.2.0]octyl, octahydropentalenyl and bicyclo[4.2.1 Jnonane.
  • the term“C3-Ci 2 -cycloalkenyl” as used herein refers to an unsaturated, monovalent, mono- or bicylic hydrocarbon ring which contains 3, 4, 5, 6, 7, 8, 9, 10, 1 1 or 12 carbon atoms.
  • Examples of monocyclic C3-C8-cycloalkenyl group include but are not limited to cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl and cyclooctenyl group.
  • Examples of bicyclic C6-Ci2-cycloalkenyl group include but are not limited to bicyclo[2.2.1 ]hept-2-enyl or bicyclo[2.2.2]oct-2-enyl.
  • aromatic C6-Ci 4 -carbocycle or“aryl” as used herein refers to an aromatic hydrocarbon ring system in which all of the ring members, which vary from 6 to 14, preferably from 6 to 10, are carbon atoms.
  • the ring system may be monocyclic or fused polycyclic (e.g. bicyclic or tricyclic).
  • aryl include but are not limited to phenyl, azulenyl, naphthyl and fluorenyl.
  • the aryl can be attached to the parent molecular moiety through any carbon atom.
  • said substituent(s) may be at any positions on said aryl ring(s). Particularly, in the case of aryl being a phenyl group, said substituent(s) may occupy one or both ortho positions, one or both meta positions, or the para position, or any combination of these positions.
  • non-aromatic 3- to 10-membered heterocycle or“heterocyclyl” as used herein refers to a saturated or partially unsaturated non-aromatic ring system comprising 1 to 4, or 1 to 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur. If the ring system contains more than one oxygen atoms, they are not directly adjacent.
  • Non aromatic heterocycles include but are not limited to 3- to 7-membered monocyclic non-aromatic heterocycles and 6- to 10-membered polycyclic (e.g. bicyclic or tricyclic) non-aromatic heterocycles.
  • the non-aromatic 3- to 10-membered heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.
  • non-aromatic 3- to 7-membered monocyclic heterocycle refers to a 3-, 4-, 5-, 6- or 7-membered monocyclic ring system containing 1 , 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur where the ring system is saturated or unsaturated but not aromatic.
  • the heterocycle may comprise one to three nitrogen atoms, or one or two oxygen atoms, or one or two sulfur atoms, or one to three nitrogen atoms and one oxygen atom, or one to three nitrogen atoms and a sulfur atom or one sulfur atom and one oxygen atom.
  • saturated non-aromatic heterocycles include but are not limited to 3-membered ring such as oxiranyl, aziridinyl, 4- membered ring such as azetidinyl, oxetanyl, thietanyl, 5-membered ring such as tetrahydrofuranyl, 1 ,3- dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, oxadiazolidinyl, thiazolidinyl, isothiazolidinyl, thiadiazolidinyl, 6-membered ring such as piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, triazinanyl, hexahydrotri
  • unsaturated non-aromatic hererocyles include but are not limited to 5-membered ring such as dihydrofuranyl, 1 ,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl or 6-membered ring such as pyranyl, thiopyranyl, thiazinyl and thiadiazinyl.
  • 5-membered ring such as dihydrofuranyl, 1 ,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl or 6-membered ring such as pyranyl, thiopyranyl, thiazinyl and
  • the two substituents together with the nitrogen atom to which they are linked can form a heterocyclyl group, preferably a 5- to 7-membered monocyclic heterocyclyl group, that can be substituted or that can include other hetero atoms, for example a morpholino group or piperidinyl group.
  • non-aromatic 6- to 10-membered polycyclic heterocycle refers to a 6-, 7-, 8-, 9-, 10-membered polycyclic (e.g. bicyclic or tricyclic) ring system containing 1 , 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur where the ring system is saturated or unsaturated but not aromatic.
  • Non-aromatic bicyclic heterocycles may consist of a monocyclic heteroaryl as defined herein fused to a monocyclic C3-C7-cycloalkyl, a monocyclic C3-C8-cycloalkenyl or a monocyclic non-aromatic heterocycle or may consist of a monocyclic non-aromatic heterocycle fused either to an aryl (e.g. phenyl), a monocyclic C3-C7-cycloalkyl, a monocyclic C3-C8-cycloalkenyl or a monocyclic non-aromatic heterocycle.
  • aryl e.g. phenyl
  • nitrogen atom may be at the bridgehead (e.g. 4, 5,6,7- tetrahydropyrazolo[1 ,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1 ,2,4]triazolo[1 ,5-a]pyridinyl, 5, 6,7,8- tetrahydroimidazo[1 ,2-a]pyridinyl).
  • Non-aromatic tricyclic heterocycles may consist of a monocyclic cycloalkyl connected through one common atom to a non-aromatic bicyclic heterocycle.
  • aromatic 5- to 14-membered heterocycle or“heteroaryl” as used herein refers to an aromatic ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur.
  • Aromatic heterocycles include aromatic 5- or 6-membered monocyclic heterocycles and 6- to 14-membered polycyclic (e.g. bicyclic ortricyclic) aromatic heterocycles.
  • the 5- to 14-membered aromatic heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.
  • aromatic 5- or 6-membered monocyclic heterocycle or“monocyclic heteroaryl” as used herein refers to a 5- or 6-membered monocyclic ring system containing 1 , 2, 3 or 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur.
  • Examples of 5-membered monocyclic heteroaryl include but are not limited to furyl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxatriazolyl, isothiazolyl, thiazolyl, thiadiazolyl and thiatriazolyl.
  • Examples of 6-membered monocyclic heteroaryl include but are not limited to pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl.
  • 6- to 14-membered polycyclic aromatic heterocycle or“polycyclic heteroaryl” as used herein refers to a 6-, 7-, 8-, 9-, 10-, 1 1 -, 12-, 13- or 14-membered polycyclic (e.g. bicyclic or tricyclic) ring system containing 1 , 2 or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen and sulfur.
  • Aromatic bicyclic heterocycles may consist of a monocyclic heteroaryl as defined herein fused to an aryl (e.g. phenyl) or to a monocyclic heteroaryl.
  • bicyclic aromatic heterocycle examples include but are not limited to 9-membered ring such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl and benzisoxazolyl or 10-membered ring such as quinolinyl, isoquinolinyl, cinnolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, naphthyridinyl, pteridinal and benzodioxinyl.
  • 9-membered ring such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl,
  • nitrogen atom may be at the bridgehead (e.g. imidazo[1 ,2-a]pyridinyl, [1 ,2,4]triazolo[4,3-a]pyridinyl, imidazo[1 ,2-a]pyridinyl, imidazo[2,1 -b]oxazolyl, furo[2,3-d]isoxazolyl).
  • Examples of tricyclic aromatic heterocyle include but are not limited to carbazolyl, acridinyl and phenazinyl.
  • non-aromatic C3-Ci 2 -carbocyclyloxy designate a group of formula -O-R wherein R is respectively a non-aromatic C3-C12- carbocyclyl, a C3-C7-cycloalkyl, an aromatic C6-Ci 4 -carbocyclyl, an aromatic 5- to 14-membered heterocyclyl or a non-aromatic 5- to 14-membered heterocyclyl group as defined herein.
  • the group when a group is said to be“substituted”, the group may be substituted with one or more substituents.
  • the expression“one or more substituents” refers to a number of substituents that ranges from one to the maximum number of substituents possible based on the number of available bonding sites, provided that the conditions of stability and chemical feasibility are met.
  • leaving group as used herein is to be understood as meaning a group which is displaced from a compound in a substitution or an elimination reaction, for example a halogen atom, a trifluoromethanesulfonate (“triflate”) group, alkoxy, methanesulfonate (“mesylate”), p-toluenesulfonate (“tosylate”), etc.
  • a halogen atom for example a halogen atom, a trifluoromethanesulfonate (“triflate”) group, alkoxy, methanesulfonate (“mesylate”), p-toluenesulfonate (“tosylate”), etc.
  • the present invention provides compounds of formula (I):
  • X is hydrogen, fluorine or chlorine
  • Y is selected from the group consisting of hydrogen, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, C2-C8- alkenyl, C2-C8-halogenoalkenyl, C2-Cs-alkynyl, C2-Cs-halogenoalkynyl, Ci-Cs-alkoxy-Ci-Cs-alkyl, tri-Ci-C8-alkylsilane, di-Ci-C8-alkyl(aryl)silane, C3-C7-cycloalkyl, C3-C7-cycloalkyl-Ci-C8-alkyl, Ci- C8-alkylcarbonyl-Ci-C8-alkyl, Ci-Cs-alkylcarbonyloxy-Ci-Cs-alkyl, aryl, aryl-Ci-Cs-alkyl, heteroaryl, heteroaryl-Ci-Cs-alkyl, di-Ci-
  • acyclic Y and Z radicals may be respectively substituted with one or more Y a or Z a substituents and wherein cyclic Y and Z radicals may be respectively substituted with one or more Y b or Z b substituents;
  • n 0, 1 or 2;
  • R 1 , R 2 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, sulfanyl, amino, formyl, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2-C8-alkenyl, C2-C8-halogenoalkenyl, C2-C8-alkynyl, C2-C8-halogenoalkynyl, Ci-Cs-alkylsulfanyl, Ci-Cs-halogenoalkylsulfanyl, Ci-Cs-alkylsulfinyl, Ci-Cs-halogenoalkylsulfinyl, Ci-Cs-alkylsulfonyl, Ci-C8-halogenoalkylsulfonyl, Ci-Cs-alkylamino, di-Ci-Cs-alkylamino, Ci
  • R 1 R 2 may form, together with the carbon atom to which they are linked, a C3-C7-cycloalkyl or a heterocyclyl ring wherein said C3-C7-cycloalkyl and heterocyclyl ring may be substituted with one or more R b substituents , or
  • acyclic R c radicals may be substituted with one or more R a substituents and wherein cyclic R c radicals may be substituted with one or more R b substituents;
  • n 0 or 1 ;
  • R 3 and R 4 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, sulfanyl, amino, formyl, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, Ci- Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2-Cs-alkenyl, C2-Cs-halogenoalkenyl, C2-Cs-alkynyl, C2-C8-halogenoalkynyl, Ci-Cs-alkylsulfanyl, Ci-Cs-halogenoalkylsulfanyl, Ci-Cs- alkylsulfinyl, Ci-Cs-halogenoalkylsulfinyl, Ci-Cs-alkylsulfonyl, Ci-Cs- halogenoalkylsulfonyl, Ci-Cs-alkylamino, di-Ci-Cs-alkylamino,
  • R 3 and R 4 may form, together with the carbon atom to which they are linked, a C3-C7-cycloalkyl or heterocyclyl, wherein said C3-C7-cycloalkyl and heterocyclyl may be substituted with one or more R b substituents, or wherein when L is CR 3 R 4 , R 1 and R 3 may form, together with the carbon atoms to which they are linked, a C3-C7-cycloalkyl ring, wherein said C3-C7-cycloalkyl ring may be substituted with one or more R b substituents,
  • R 5 is selected from the group consisting of hydrogen atom, Ci-Cs-alkyl, Ci-Cs- halogenoalkyl, C2-C8-alkenyl, C2-C8-halogenoalkenyl, C3-Cs-alkynyl, C3-Cs-halogenoalkynyl, C3- C7-cycloalkyl, C3-C7-cycloalkyl-Ci-C8-alkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-halogenoalkyl-carbonyl, C3-C7-cycloalkylcarbonyl, Ci-Cs-alkoxycarbonyl, Ci-Cs-halogenoalkoxycarbonyl, Ci-Cs- alkylsulfonyl, Ci-Cs-halogenoalkylsulfonyl, arylsulfonyl, aryl, heterocyclyl, heteroaryl, aryl-Ci-
  • A is C3-C7-cycloalkyl, aryl, heterocyclyl or heteroaryl ring, wherein said C3-C7-cycloalkyl, aryl, heterocyclyl or heteroaryl may be substituted, one or more times, in the same way or differently, with R 6 ,
  • R 6 is selected from the group consisting of halogen, cyano, hydroxy, sulfanyl, amino, nitro, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2- Ce-alkenyl, C2-Cs-halogenoalkenyl, C2-Cs-alkynyl, C2-Cs-halogenoalkynyl, Ci-Cs- alkylsulfanyl, Ci-Cs-halogenoalkyl-sulfanyl, Ci-Cs-alkylsulfinyl, Ci-Cs- halogenoalkylsulfinyl, Ci-Cs-alkylsulfonyl, Ci-Cs-halogenoalkyl-sulfonyl, Ci-Cs- alkylamino, di-Ci-Cs-alkylamino, C3-C7-
  • R 7 is selected from the group consisting of hydrogen, Ci-Cs-alkyl, Ci-Cs- haloalkyl, C2-C8-alkenyl, C2-C8-halogenoalkenyl, C2-C8-alkynyl, C2-C8- halogenoalkynyl, C3-C7-cycloalkyl, aryl, heteroaryl, aryl-Ci-Cs-alkyl and heteroaryl-Ci-Cs-alkyl,
  • R 8 is selected from the group consisting of hydrogen, hydroxy, amino, cyano, Ci-Cs-alkyl, Ci-Cs-haloalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2-C8- alkenyl, C2-Cs-halogenoalkenyl, C2-C8-alkynyl, C2-C8-halogenoalkynyl, Ci-Cs- alkylamino, di-Ci-Cs-alkylamino, C3-C7-cycloalkyl, aryl, heteroaryl, aryl-Ci-Cs- alkyl, heteroaryl-Ci-Cs-alkyl, aryloxy, heteroaryloxy, arylamino and heteroarylamino, or
  • acyclic R 6 , R 7 and R 8 radicals may be substituted with one or more R a substituents and wherein cyclic R 6 , R 7 and R 8 radicals may be substituted with one or more R b substituents;
  • R a , Y a and Z a are independently selected from the group consisting of nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro- 6 -sulfanyl, formyl, carbamoyl, carbamate, C3-C7-cycloalkyl, C3-C7-halogenocycloalkyl,Ci-C8-alkylamino, di-Ci-Cs-alkylamino, Ci-Cs-alkoxy, Ci-Cs- halogenoalkoxy, Ci-Cs-alkylsulfanyl, Ci-Cs-halogenoalkylsulfanyl, Ci-Cs-alkylcarbonyl, Ci-Cs- halogenoalkylcarbonyl, Ci-Cs-alkylcarbamoyl, di-Ci-Cs-alkylcarbamoyl, Ci-Cs-alkoxycarbonyl
  • the invention encompasses pure stereoisomers of the compound of formula (I) and any mixture of these isomers.
  • the compound of fomula (I) may be present in the form of different stereoisomers. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers. Where a compound can be present in two or more tautomer forms in equilibrium, reference to the compound by means of one tautomeric description is to be considered to include all tautomer forms.
  • the compounds of fomula (I) can suitably be in their free form, salt form, N-oxide form or solvate form (e.g. hydrate).
  • the compound of fomula (I) may be present in the form of the free compound and/or a salt thereof, such as an agrochemically active salt.
  • Agrochemically active salts include acid addition salts of inorganic and organic acids well as salts of customary bases.
  • inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acidic salts, such as sodium bisulfate and potassium bisulfate.
  • Useful organic acids include, for example, formic acid, carbonic acid and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or mono- or diunsaturated fatty acids having 6 to 20 carbon atoms, alkylsulfuric monoesters, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl, which bear one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylphosphonic
  • Solvates of the compounds of the invention or their salts are stoichiometric compositions of the compounds with solvents.
  • the compounds of the invention may exist in multiple crystalline and/or amorphous forms.
  • Crystalline forms include unsolvated crystalline forms, solvates and hydrates.
  • X is fluorine.
  • Z is selected from the group consisting of Ci-Cs-alkyl, Ci-Ce-halogenoalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, Ci-Cs-alkylamino, di-Ci-Cs-alkylamino, aryloxy and heteroaryloxy.
  • Z is Ci-Cs-alkyl (preferably Ci-C 4 -alkyl, e.g. methyl or ethyl), Ci-Cs-alkoxy (preferably Ci-C 4 -alkoxy, e.g. methoxy, ethoxy or te/ -butoxy) or phenyloxy.
  • Y is hydrogen, fe/?-butyl(dimethyl)silane or acetyl.
  • m is 0 or 1 .
  • m 0.
  • n 0.
  • n 1 .
  • L is NR 5 with R 5 being selected from the group consisting of hydrogen atom, Ci-Cs-alkyl, C3-C7-cycloalkyl-Ci-C8-alkyl, Ci-Cs-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, Ci-C8-alkylsulfonyl, Ci-Cs-halogenoalkylsulfonyl, arylsulfonyl and aryl-Ci-Cs-alkyl.
  • L is NR 5 with R 5 being selected from the group consisting of hydrogen atom, Ci-C 4 -alkyl (eg. methyl), C3-C7-cycloalkyl-Ci-C8-alkyl (e.g. cyclopropylmethyl), C1-C4- alkylcarbonyl (e.g. acyl) , Ci-C 4 -alkoxycarbonyl (e.g. methoxycarbonyl or ethoxycarbonyl), C1-C4- alkylsulfonyl (e.g. mesyl), Ci-C 4 -halogenoalkylsulfonyl (e.g. triflyl), arylsulfonyl (e.g. phenylsulfonyl or tosyl) and aryl-Ci-C 4 -alkyl (e.g. benzyl).
  • R 5 being selected from the group consisting of hydrogen atom, Ci-C 4
  • L is NR 5 with R 5 being hydrogen.
  • n 1 and L is is NR 5 , preferably NH.
  • R 3 and R 4 are independently selected from the group consisting of hydrogen and Ci-Cs-alkyl.
  • R 3 and R 4 are hydrogen.
  • A is C3-C7-cycloalkyl, aryl or heteroaryl ring. A may be substituted as described herein above or below.
  • A is C3-C7-cycloalkyl, preferably cyclopentyl or cyclohexyl. A may be substituted as described herein above or below.
  • A is phenyl. A may be substituted as described herein above or below.
  • A is a heteroaryl ring, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrole, thiophene, thiazole, pyridine, pyrimidine, pyrazine, indol, benzothiazine and phenothiazine.
  • A may be substituted as described herein above or below.
  • A is a 5- or 6-membered heteroaryl ring, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrole, thiophene, thiazole, pyridine, pyrimidine and pyrazine.
  • A may be substituted as described herein above or below.
  • A is a heterocyclyl ring, such as tetrahydro-2H-pyrane,
  • A is cyclopentyl, cyclohexyl, phenyl, imidazole, pyrazole,
  • A is selected from the group consisting of 5- or 6- membered heteroaryl, phenyl and C3-C7-cycloalkyl, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, phenyl, cyclohexyl and cyclopentyl.
  • A may be substituted as described herein above or below.
  • A is selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, indole, benzothiazine, phenothiazine, tetrahydropyrane, 1 ,2-dihydropyridine, 2,3-dihydro-4H-1 ,4-benzothiazine, 4, 5,6,7- tetrahydropyrazolo-[1 ,5-a]-pyridine or 1 ,2,3,4-tetrahydrocarbazole, phenyl, cyclohexyl and cyclopentyl.
  • A may be substituted as described herein above or below.
  • R 6 which is selected from the group consisting of halogen (e.g. Cl or F), Ci-C 4 -alkyl (e.g. methyl), Ci-C 4 -alkoxy (e.g. methoxy), C3-C7-cycloalkyl (e.g. cyclopropyl
  • R 6 is selected from the group consisting of halogen (e.g. Cl or F), cyano, Ci-C 4 -alkyl (e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl), Ci-C 4 -halogenoalkyl (e.g. trifluoromethyl, difluoromethyl or trifluoroethyl), Ci-C 4 -alkoxy (e.g. methoxy), Ci-C 4 -alkylamino (e.g. dimethylamino), C3-C7-cycloalkyl (e.g.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl
  • Ci-C 4 -halogenoalkyl e.g. trifluoromethyl, difluoromethyl or trifluoroe
  • R 7 is selected from the group consisting of hydrogen, Ci- Ce-alkyl, aryl and C3-C7-cycloalkyl. R 7 may be substituted as described herein.
  • R 7 is selected from the group consisting of hydrogen, methyl, ethyl, phenyl, 4-chlorophenyl and cyclopropyl.
  • R 8 is selected from the group consisting of hydrogen and Ci-C8-alkyl.
  • R 8 is selected from the group consisting of hydrogen and methyl.
  • R c is as described herein.
  • R 1 and R 2 are independently selected from the group hydrogen, hydroxy, methyl, methoxy and acetoxy, or R 1 and R 2 may form, together with the carbon atom to which they are linked, a cyclopropyl ring.
  • compounds are excluded, in which in the above formula (I) n is 0, A is a N-linked heterocyclyl ring, and R 1 and R 2 are selected from the group consisting of hydrogen, halogen, cyano, Ci- C 4 -alkyl, Ci-C 4 -halogenoalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl and Ci-C 4 -alkoxy; and compounds are excluded, in which in the above formula (I) n is 0, A is a N-linked heterocyclyl ring, and R 1 and R 2 form, togetherwith the carbon atom to which they are linked, a C3-C7-cycloalkyl or a 3- to 6-membered saturated heterocyclyl ring that contains 1 to 3 heteroatoms that can be the same or different and selected from the group consisting of O, S and N.
  • Non-limiting examples of sub-classes of compounds include the sub-classes described herein below.
  • embodiment l-a the present invention relates to compound of formula (I):
  • X is fluorine
  • n 0 or 1 ;
  • R 1 , R 2 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, sulfanyl, amino, formyl, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2-C8-alkenyl, C2-C8-halogenoalkenyl, C2-Cs-alkynyl, C2-Cs-halogenoalkynyl, Ci-Cs-alkylsulfanyl, Ci-Ce-halogenoalkylsulfanyl, Ci-Cs-alkylsulfinyl, Ci-Cs-halogenoalkylsulfinyl, Ci-Cs-alkylsulfonyl, Ci-C8-halogenoalkylsulfonyl, Ci-Cs-alkylamino, di-Ci-Cs-alkylamino, Ci
  • acyclic R c radicals may be substituted with one or more R a substituents as described herein and wherein cyclic R c radicals may be substituted with one or more R b substituents as described herein;
  • n 0 or 1 ;
  • R 1 and R 3 may form, together with the carbon atoms to which they are linked, a C3-C7-cycloalkyl ring, wherein said C3-C7-cycloalkyl ring may be substituted with one or more R b substituents as described herein,
  • A is C3-C7-cycloalkyl, aryl, heterocyclyl or heteroaryl ring, wherein said C3-C7-cycloalkyl, aryl, heterocyclyl or heteroaryl may be substituted, one or more times, in the same way or differently, with R 6 , R 6 being as described herein;
  • embodiment l-b the present invention relates to compound of formula (I):
  • X is fluorine
  • R 1 , R 2 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, sulfanyl, amino, formyl, Ci-Cs-alkyl, Ci-Cs-halogenoalkyl, Ci-Cs-alkoxy, Ci-Cs-halogenoalkoxy, C2-C8-alkenyl, C2-C8-halogenoalkenyl, C2-C8-alkynyl, C2-C8-halogenoalkynyl, Ci-Cs-alkylsulfanyl, Ci-C8-halogenoalkylsulfanyl, Ci-Cs-alkylsulfinyl, Ci-Cs-halogenoalkylsulfinyl, Ci-Cs-alkylsulfonyl, Ci-C8-halogenoalkylsulfonyl, Ci-Cs-alkylamino, di-Ci-Cs
  • R 1 R 2 may form, together with the carbon atom to which they are linked, a C3-C7-cycloalkyl or a heterocyclyl ring wherein said C3-C7-cycloalkyl and heterocyclyl ring may be substituted with one or more R b substituents as described herein, or
  • acyclic R c radicals may be substituted with one or more R a substituents as described herein and wherein cyclic R c radicals may be substituted with one or more R b substituents as described herein;
  • n 0 or 1 ;
  • R 1 and R 3 may form, together with the carbon atoms to which they are linked, a C3-C7-cycloalkyl ring, wherein said C3-C7-cycloalkyl ring may be substituted with one or more R b substituents as described herein,
  • A is C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring, wherein said C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring may be substituted, one or more times, in the same way or differently, with R 6 , R 6 being as described herein;
  • embodiment l-c the present invention relates to compound of formula (I): wherein
  • X is fluorine
  • n 0 or 1 ;
  • R 1 and R 3 may form, together with the carbon atoms to which they are linked, a C3-C7-cycloalkyl ring, wherein said C3-C7-cycloalkyl ring may be substituted with one or more R b substituents,
  • A is C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring, wherein said C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring may be substituted, one or more times, in the same way or differently, with R 6 , R 6 being as described herein; provided that the compound of formula (I) is not :
  • Y is hydrogen, tert- butyl(dimethyl)silane or acetyl.
  • m is 0.
  • n 0.
  • n is 1 .
  • n is 0.
  • n 1 and L is is NR 5 , preferably NH.
  • R 3 and R 4 being independently selected from the group consisting of hydrogen and Ci-Cs-alkyl
  • R 5 being selected from the group consisting of hydrogen atom, Ci-Cs-alkyl, C3-C7-cycloalkyl-Ci-C8-alkyl, Ci-Ce-alkylcarbonyl, Ci-Cs-alkoxycarbonyl, Ci-Cs-alkylsulfonyl, Ci-Cs-halogenoalkylsulfonyl, arylsulfonyl and aryl-Ci-Ce-alkyl.
  • A is a heteroaryl ring, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrole, thiophene, thiazole, pyridine, pyrimidine, pyrazine, indol, benzothiazine and phenothiazine.
  • A may be substituted as described herein above or below.
  • A is a 5- or 6-membered heteroaryl ring, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrole, thiophene, thiazole, pyridine, pyrimidine and pyrazine.
  • A may be substituted as described herein above or below.
  • A is a heterocyclyl ring, such as tetrahydro-2H-pyrane, 1 ,2-dihydropyridine, 2,3-dihydro-4H-1 ,4-benzothiazine, 4, 5,6,7- tetrahydropyrazolo-[1 ,5-a]-pyridine or 1 ,2,3,4-tetrahydrocarbazol.
  • A may be substituted as described herein above or below.
  • A is selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, indole, benzothiazine, phenothiazine, tetrahydropyrane, 1 ,2-dihydropyridine, 2, 3-dihydro-4H-1 ,4- benzothiazine, 4,5,6,7-tetrahydropyrazolo-[1 ,5-a]-pyridine or 1 ,2,3,4-tetrahydrocarbazole, phenyl, cyclohexyl and cyclopentyl.
  • A may be substituted as described herein above or below.
  • A is selected from the group consisting of 5- or 6-membered heteroaryl, phenyl and C3-C7-cycloalkyl, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, phenyl, cyclohexyl and cyclopentyl.
  • A may be substituted as described herein above or below.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl
  • Ci-C 4 -alkoxy e.g. methoxy
  • C3-C7-cycloalkyl e.g. cyclopropyl
  • aryl e.g., phen
  • R 6 is selected from the group consisting of halogen (e.g. Cl or F), cyano, Ci-C 4 -alkyl (e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl), Ci-C 4 -halogenoalkyl (e.g. trifluoromethyl, difluoromethyl or trifluoroethyl), Ci-C 4 -alkoxy (e.g. methoxy), Ci- C 4 -alkylamino (e.g. dimethylamino), C3-C7-cycloalkyl (e.g.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl
  • Ci-C 4 -halogenoalkyl e.g. trifluoromethyl, difluoromethyl or trifluoroe
  • cyclopropyl, cyclopentyl aryl (e.g. phenyl, 4- chlorophenyl), aryl-Ci-C 4 -alkyl (e.g. benzyl, 2-fluorobenzyl), heteroaryl-Ci-C 4 -alkyl (e.g.
  • A is imidazole, pyrazole, 1 ,2- oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, indole, benzothiazine, phenothiazine, tetrahydropyrane, 1 ,2-dihydropyridine, 2,3-dihydro-4H-1 ,4-benzothiazine, 4,5,6,7-tetrahydropyrazolo- [1 ,5-a]-pyridine or 1 ,2,3,4-tetrahydrocarbazole, phenyl, cyclohexyl and cyclopentyl.
  • A may be substituted with R 6 as described herein.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl
  • Ci-C 4 -alkoxy e.g. methoxy
  • R 7 is selected from the group consisting of hydrogen, Ci-Cs-alkyl and aryl. R 7 may be substituted as described herein.
  • R 7 is selected from the group consisting of hydrogen, methyl, ethyl, phenyl and 4- chlorophenyl.
  • R 8 is selected from the group consisting of hydrogen and Ci-Cs-alkyl.
  • R 8 is selected from the group consisting of hydrogen and methyl.
  • R c is as described herein.
  • R 1 and R 2 are independently selected from the group hydrogen, hydroxy, methyl, methoxy and acetoxy, or R 1 and R 2 may form, together with the carbon atom to which they are linked, a cyclopropyl ring.
  • embodiment l-d the present invention relates to compound of formula (I): wherein
  • X is fluorine
  • n 0;
  • R 1 and R 2 are independently selected from the group consisting of hydrogen, hydroxy, Ci-Cs-alkyl, Ci-Ce-alkoxy and Ci-Cs-alkoxycarbonyl, or
  • n 0 or 1 ;
  • R 3 and R 4 are independently hydrogen and Ci-Cs-alkyl and wherein R 5 is selected from the group consisting of hydrogen atom, Ci-Cs-alkyl, C3-C7-cycloalkyl-Ci-C8-alkyl, Ci-Cs- alkylcarbonyl, Ci-Cs-alkoxycarbonyl, Ci-Cs-alkylsulfonyl, Ci-Cs-halogenoalkylsulfonyl, arylsulfonyl and aryl-Ci-Cs-alkyl;
  • A is a C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring, preferably selected from the group consisting of phenyl, cyclopentyl, cyclohexyl, imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine and pyrazine,
  • A may be substituted with one or more substituents R 6 ;
  • R 6 is selected from the group consisting of halogen (e.g. Cl or F), cyano, Ci-C 4 -alkyl (e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl), Ci-C 4 -halogenoalkyl (e.g. trifluoromethyl, difluoromethyl or trifluoroethyl), Ci-C 4 -alkoxy (e.g. methoxy), Ci- C 4 -alkylamino (e.g. dimethylamino), C3-C7-cycloalkyl (e.g.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl
  • Ci-C 4 -halogenoalkyl e.g. trifluoromethyl, difluoromethyl or trifluoroe
  • aryl e.g. phenyl, 4- chlorophenyl
  • aryl-Ci-C 4 -alkyl e.g. benzyl, 2-fluorobenzyl
  • n 0.
  • n is 0 or n is 1 and L is CH2.
  • n 1 .
  • n is 1 and L is is NR 5 , preferably NH.
  • A is selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, pyridine, pyrimidine, pyrazine, phenyl, cyclohexyl and cyclopentyl.
  • embodiment l-e the present invention relates to compound of formula (I):
  • X is fluorine
  • Y is hydrogen, fe/?-butyl(dimethyl)silane or acetyl
  • n 0;
  • n 0 or 1 ;
  • A is a C3-C7-cycloalkyl, phenyl or 5- or 6-membered heteroaryl ring, preferably selected from the group consisting of imidazole, pyrazole, 1 ,2-oxazole, pyrrol, thiophene, thiazole, pyridine, pyrimidine, pyrazine, phenyl, cyclohexyl and cyclopentyl, wherein A may be substituted with one or more substituents R 6 ;
  • R 6 is selected from the group consisting of halogen (e.g. Cl or F), cyano, Ci-C 4 -alkyl (e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl), Ci-C 4 -halogenoalkyl (e.g. trifluoromethyl, difluoromethyl or trifluoroethyl), Ci-C 4 -alkoxy (e.g. methoxy), Ci- C 4 -alkylamino (e.g. dimethylamino), C3-C7-cycloalkyl (e.g.
  • halogen e.g. Cl or F
  • Ci-C 4 -alkyl e.g. methyl, ethyl, n-propyl, isopropyl, isobutyl
  • Ci-C 4 -halogenoalkyl e.g. trifluoromethyl, difluoromethyl or trifluoroe
  • aryl e.g. phenyl, 4- chlorophenyl
  • aryl-Ci-C 4 -alkyl e.g. benzyl, 2-fluorobenzyl
  • n 0.
  • n is 0 or n is 1 and L is CH2.
  • n 1 .
  • n is 1 and L is is NR 5 , preferably NH.
  • the present invention also relates to any compounds of formula (I) disclosed in Table 1 :
  • the compounds of formula (I) according to the present invention may be used as fungicides (i.e. for controlling phytopathogenic fungi, in particular fungi causing rust diseases, or Oomyctes in crop protection). Processes for the preparation of compounds of formula (I) and intermediates
  • the present invention also relates to processes for the preparation of compounds of formula (I).
  • the radicals X, Y, R 1 , R 2 , R 3 , R 4 , L and A, and integers m and n have the meanings given above for the compounds of formula (I). These definitions apply not only to the end products of the formula (I) but likewise to all intermediates.
  • Process P1 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Process P1 can be carried out in the presence of a catalyst, such as a metal salt or complex.
  • a catalyst such as a metal salt or complex.
  • Suitable metal derivatives for this purpose are transition metal catalysts such as palladium.
  • Suitable metal salts or complexes for this purpose are for example, palladium chloride, palladium acetate, tetrakis(triphenylphosphine)palladium(0), bis(dibenzylideneacetone)palladium(0), tris(dibenzylidene- acetone)dipalladium(O), bis(triphenylphosphine)palladium(ll) dichloride, [1 ,1’-bis(diphenylphosphino)- ferrocene]dichloropalladium(ll), bis(cinnamyl)dichlorodipalladium(ll), bis(allyl)-dichlorodipalladium(ll) or [1 ,1’-Bis(d
  • a palladium complex in the reaction mixture by separate addition to the reaction of a palladium salt and a ligand or salt, such as triethylphosphine, tri-te/ -butylphosphine, tri -tert- butylphosphonium tetrafluoroborate, tricyclohexylphosphine, 2-(dicyclohexylphosphino)biphenyl, 2-(di- fe/?-butylphosphino)biphenyl, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2- ⁇ tert- butylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-di-fe/?-butylphosphino-2’,4’,6’-triisopropylbiphenyl 2- dicyclohexy
  • catalyst and/or ligand from commercial catalogues such as “Metal Catalysts for Organic Synthesis” by Strem Chemicals or “Phosphorous Ligands and Compounds” by Strem Chemicals.
  • Suitable bases for carrying out Process P1 can be inorganic and organic bases which are customary for such reactions.
  • Suitable solvents for carrying out process P1 can be customary inert organic solvents. Preference is given to using optionally halogenated, aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane; ethers, such as diethyl ether, diisopropyl ether, methyl f-butyl ether, methyl f-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1 ,2-dimethoxyethane, 1 ,2-diethoxyethane or anisole; n
  • process P1 can also be advantageous to carry out process P1 with a co-solvent such as water or an alcohol such as methanol, ethanol, propanol, isopropanol or fe/ -butanol.
  • a co-solvent such as water or an alcohol such as methanol, ethanol, propanol, isopropanol or fe/ -butanol.
  • Process P1 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (III) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a palladium complex can be employed per mole of compound of formula (II). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P2 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Halogenated derivatives of formula (V) are commercially available or can be prepared by known processes.
  • Suitable catalysts, bases and solvents for carrying out process P2 can be as disclosed in connection with process P1 .
  • Process P2 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (V) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a palladium complex can be employed per mole of compound of formula (IV). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P3 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Organometallic compounds of formula (VII) are commercially available or can can be obtained from the corresponding halogenated derivative by reaction with magnesium metal, zinc metal or lithium metal preferably under anhydrous conditions ; or by halogen/metal exchange using an alkyllithium reagent or a Grignard reagent or a manufactured complex prepared from an alkyllithium reagent or a Grignard reagent preferably under anhydrous conditions ; or by metal/metal exchange using zinc chloride on a Grignard reagent preferably under anhydrous conditions, according to known processes.
  • Suitable solvents for carrying out process P3 can be customary inert organic solvents. Preference is given to using optionally halogenated, aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; ethers, such as diethyl ether, diisopropyl ether, methyl fe/ -butyl ether, methyl fe/ -amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1 ,2-dimethoxyethane, 1 ,2-diethoxyethane or anisole ; and a mixture thereof.
  • optionally halogenated, aliphatic, alicyclic or aromatic hydrocarbons such as petroleum ether, pentane, he
  • Suitable catalysts and bases for carrying out process P3 can be as disclosed in connection with process P1.
  • Process P3 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (VII) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a palladium complex can be employed per mole of compound of formula (VI). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P4 can be performed if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Phenols, thiophenols and anilines and the like of formula (VIII) are commercially available or can be prepared by known processes.
  • Suitable bases and solvents for carrying out process P4 can be as disclosed in connection with process P1.
  • Other suitable bases for carrying out process P4 according to the invention can be amides or organometallic derivatives.
  • alkali metal hydrides such as lithium hydride, sodium hydride or potassium hydride
  • alkali metal amides such as sodium amide or potassium amide
  • organic amides such as lithium diisopropylamine (LDA), lithium tetramethylpiperidide, lithium hexamethyldisilazane (LiHMDS), potassium hexamethyldisilazane (KHMDS) or sodium hexamethyldisilazane (NaHMDS)
  • organolithium derivatives such as methyllithium, phenyllithium, n- butyllithium, sec-butyllithium, iso-butyllithium or te/ -butyllithium.
  • Process P4 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (VIII) and from 1 to 5 moles of base can be employed per mole of compound of formula (II). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P5 can be performed in the presence of a solvent according to known processes.
  • Organometallic derivatives of formula (X) are commercially available or can be prepared by known processes.
  • Suitable solvents for carrying out process P5 can be as disclosed in connection with process P3.
  • Process P5 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (X) can be employed per mole of compound of formula (IX). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P6 [reductive amination] can be performed according to“Reduction of Imines and Reductive Amination of Aldehydes and Ketones” in Science of Synthesis 4.17, Section 2.6.
  • Anilines of formula (Villa) are commercially available or can be prepared by known processes.
  • Suitable solvents for carrying out process P6 can be as disclosed in connection with process P1 .
  • Process P6 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (Villa) and from 1 to 5 moles of reductant can be employed per mole of compound of formula (IXa). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P7 [nucleophilic substitution] can be performed if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Heterocyclyl rings A (XI) bearing a free NH group are commercially available or can be prepared by known processes.
  • Suitable bases and solvents for carrying out process P7 can be as disclosed in connection with process P4.
  • Process P7 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (XI) and from 1 to 5 moles of base can be employed per mole of compound of formula (II). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Process P8 can be performed if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes.
  • Suitable bases and solvents for carrying out process P8 can be as disclosed in connection with process P1 .
  • Process P8 may be performed in an inert atmosphere such as argon or nitrogen atmosphere.
  • an inert atmosphere such as argon or nitrogen atmosphere.
  • 1 mole or an excess of compound of formula (XII) and from 1 to 5 moles of base can be employed per mole of compound of formula (I) wherein Y is hydrogen. It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
  • Processes P1 , P2, P3, P4, P5, P6, P7 and P8 are generally carried out under atmospheric pressure. It is also possible to operate under elevated or reduced pressure.
  • reaction temperatures can be varied within a relatively wide range. In general, these processes are carried out at temperatures from -78 °C to 200 °C, preferably from - 78 °C to 150 °C.
  • a way to control the temperature for the processes is to use microwave technology.
  • reaction mixture is concentrated under reduced pressure.
  • residue that remains can be freed by known methods, such as chromatography or crystallization, from any impurities that can still be present.
  • compositions and formulations are provided.
  • the present invention further relates to a composition, in particular a composition for controlling unwanted microorganisms, comprising one or more compounds of formula (I).
  • the composition is preferably is a fungicidal composition.
  • the composition typically comprises one or more compounds of formula (I) and one or more acceptable carriers, in particular one or more agriculturally acceptable carriers.
  • a carrier is a solid or liquid, natural or synthetic, organic or inorganic substance that is generally inert.
  • the carrier generally improves the application of the compounds, for instance, to plants, plants parts or seeds.
  • suitable solid carriers include, but are not limited to, ammonium salts, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, and synthetic rock flours, such as finely divided silica, alumina and silicates.
  • typically useful solid carriers for preparing granules include, but are not limited to crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks.
  • suitable liquid carriers include, but are not limited to, water, organic solvents and combinations thereof.
  • suitable solvents include polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as butanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide), lactams (such as N-alkylpyrrolidones) and lactones, sulf
  • the carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
  • the amount of carrier typically ranges from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the composition.
  • composition may further comprise one or more acceptable auxiliaries which are customary for formulating compositions (e.g. agrochemical compositions), such as one or more surfactants.
  • acceptable auxiliaries which are customary for formulating compositions (e.g. agrochemical compositions), such as one or more surfactants.
  • the surfactant can be an ionic (cationic or anionic) or non-ionic surfactant, such as ionic or non-ionic emulsifier(s), foam former(s), dispersant(s), wetting agent(s) and any mixtures thereof.
  • surfactants include, but are not limited to, salts of polyacrylic acid, salts of lignosulfonic acid, salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene and/or propylene oxide with fatty alcohols, fatty acids or fatty amines (polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols and derivatives of compounds containing sulfates, sulfonates, phosphates (for example, alkylsulfonates, alkyl sulfates, arylsulfonates) and protein hydroly
  • auxiliaries which are customary for formulating agrochemical compositions include water repellents, siccatives, binders (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose), thickeners, stabilizers (e.g.
  • dyes or pigments such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue ; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g. silicone antifoams and magnesium stearate), preservatives (e.g.
  • dichlorophene and benzyl alcohol hemiformal secondary thickeners (cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica), stickers, gibberellins and processing auxiliaries, mineral and vegetable oils, perfumes, waxes, nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers.
  • secondary thickeners cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica
  • stickers gibberellins and processing auxiliaries
  • mineral and vegetable oils perfumes
  • waxes including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc
  • protective colloids including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molyb
  • auxiliaries are related to the intended mode of application of the compound of the formula (I) and/or on the physical properties. Furthermore, the auxiliaries may be chosen to impart particular properties (technical, physical and/or biological properties) to the compositions or use forms prepared therefrom. The choice of auxiliaries may allow customizing the compositions to specific needs.
  • the composition may be in any customary form, such as solutions (e.g aqueous solutions), emulsions, wettable powders, water- and oil-based suspensions, powders, dusts, pastes, soluble powders, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural or synthetic products impregnated with the compoundof theinvention, fertilizers and also microencapsulations in polymeric substances.
  • the compound of formula (I) may be present in a suspended, emulsified or dissolved form.
  • compositions may be provided to the end user as ready-for-use formulation, i.e. the compositions may be directly applied to the plants or seeds by a suitable device, such as a spraying or dusting device.
  • a suitable device such as a spraying or dusting device.
  • the composition may be provided to the end user in the form of concentrates which have to be diluted, preferably with water, prior to use.
  • the composition can be prepared in conventional manners, for example by mixing the compound formula (I) with one or more suitable auxiliaries, such as disclosed herein above.
  • the composition contains generally from 0.01 to 99% by weight, from 0.05 to 98% by weight, preferably from 0.1 to 95% by weight, more preferably from 0.5 to 90% by weight, most preferably from 1 to 80% by weight of the compound of formula (I).
  • the compound(s) and composition(s) comprising thereof can be mixed with other active ingredients like fungicides, bactericides, acaricides, nematicides, insecticides, herbicides, fertilizers, growth regulators, safeners or semiochemicals. This may allow to broaden the activity spectrum or to prevent development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides and bactericides are disclosed in the Pesticide Manual, 17th Edition.
  • fungicides which could be mixed with the compound(s) of formula (I) and the composition of the invention are:
  • Inhibitors of the ergosterol biosynthesis for example (1 .001) cyproconazole, (1 .002) difenoconazole, (1 .003) epoxiconazole, (1 .004) fenhexamid, (1 .005) fenpropidin, (1 .006) fenpropimorph, (1 .007) fenpyrazamine, (1 .008) fluquinconazole, (1 .009) flutriafol, (1 .010) imazalil, (1 .01 1) imazalil sulfate, (1 .012) ipconazole, (1 .013) metconazole, (1 .014) myclobutanil, (1 .015) paclobutrazol, (1 .016) prochloraz, (1 .017) propiconazole, (1 .018) prothioconazole, (1 .019) pyrisoxazole, (1 .020) spiroxamine, (1 .021) te
  • Mefentrifluconazole (1 .056) 2- ⁇ [3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl ⁇ -2,4-dihydro- 3H-1 ,2,4-triazole-3-thione, (1 .057) 2- ⁇ [rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2- yl]methyl ⁇ -2,4-dihydro-3H-1 ,2,4-triazole-3-thione, (1 .058) 2- ⁇ [rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4- difluorophenyl)oxiran-2-yl]methyl ⁇ -2,4-dihydro-3H-1 ,2,4-triazole-3-thione, (1 .059) 5-(4-chlorobenzyl)-2- (chloromethyl)-2-
  • Inhibitors of the respiratory chain at complex I or II for example (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furametpyr, (2.009) Isofetamid, (2.010) isopyrazam (anti-epimeric enantiomer 1 R,4S,9S), (2.01 1) isopyrazam (anti-epimeric enantiomer 1 S,4R,9R), (2.012) isopyrazam (anti-epimeric racemate 1 RS,4SR,9SR), (2.013) isopyrazam (mixture of syn-epimeric racemate 1 RS,4SR,9RS and anti-epimeric racemate 1 RS,4SR,9SR), (2.014) isopyrazam (syn-epimeric enantiomer 1 R,
  • Inhibitors of the respiratory chain at complex III for example (3.001) ametoctradin, (3.002) amisulbrom,
  • Inhibitors of the mitosis and cell division for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) pencycuron, (4.006) thiabendazole, (4.007) thiophanate- methyl, (4.008) zoxamide, (4.009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine, (4.010) 3- chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (4.01 1) 3-chloro-5-(6-chloropyridin-
  • Inhibitors of the amino acid and/or protein biosynthesis for example (7.001 ) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1 -yl)quinoline.
  • Inhibitors of the ATP production for example (8.001) silthiofam.
  • Inhibitors of the cell wall synthesis for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-fe/if-butylphenyl)-3-(2-chloropyridin-4-yl)-1 -(morpholin-4-yl)prop-2-en-1 -one, (9.009) (2Z)-3-(4- fe/?-butylphenyl)-3-(2-chloropyridin-4-yl)-1 -(morpholin-4-yl)prop-2-en-1 -one.
  • Inhibitors of the lipid and membrane synthesis for example (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos-methyl.
  • Inhibitors of the melanin biosynthesis for example (1 1 .001 ) tricyclazole, (1 1 .002) 2,2,2-trifluoroethyl ⁇ 3-methyl-1 -[(4-methylbenzoyl)amino]butan-2-yl ⁇ carbamate.
  • Inhibitors of the nucleic acid synthesis for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).
  • Inhibitors of the signal transduction for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin.
  • fungicides selected from the group consisting of (15.001) abscisic acid, (15.002) benthiazole, (15.003) bethoxazin, (15.004) capsimycin, (15.005) carvone, (15.006) chinomethionat, (15.007) cufraneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.01 1) flutianil, (15.012) fosetyl- aluminium, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickel dimethyldithiocarbamate, (15.020) nitrothal-isopropyl, (15.021) oxamocarb, (15.022) Oxathiapiprolin, (15.023) oxy
  • the compounds of formula (I) and compositions comprising thereof may be combined with one or more biological control agents.
  • biological control agents which may be combined with the compounds of formula (I) and compositions comprising thereof are:
  • Antibacterial agents selected from the group of:
  • (A1) bacteria such as (A1 .1) Bacillus subtilis, in particular strain QST713/AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL Accession No. B21661 and described in U.S. Patent No. 6,060,051); (A1 .2) Bacillus amyloliquefaciens, in particular strain D747 (available as Double NickelTM from Certis, US, having accession number FERM BP-8234 and disclosed in US Patent No. 7,094,592); (A1 .3) Bacillus pumilus, in particular strain BU F-33 (having NRRL Accession No.
  • (A2) fungi such as (A2.1) Aureobasidium pullulans, in particular blastospores of strain DSM14940; (A2.2) Aureobasidium pullulans blastospores of strain DSM 14941 ; (A2.3) Aureobasidium pullulans, in particular mixtures of blastospores of strains DSM14940 and DSM14941 ;
  • (B1) bacteria for example (B1 .1 ) Bacillus subtilis, in particular strain QST713/AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL Accession No. B21661 and described in U.S. Patent No. 6,060,051); (B1 .2) Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, US, having Accession No. NRRL B-30087 and described in U.S. Patent No.
  • Bacillus pumilus in particular strain GB34 (available as Yield Shield® from Bayer AG, DE); (B1 .4) Bacillus pumilus, in particular strain BU F-33 (having NRRL Accession No. 50185); (B1 .5) Bacillus amyloliquefaciens, in particular strain D747 (available as Double NickelTM from Certis, US, having accession number FERM BP-8234 and disclosed in US Patent No. 7,094,592); (B1 .6) Bacillus subtilis Y1336 (available as BIOBAC ® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos.
  • Bacillus amyloliquefaciens strain MBI 600 (available as SUBTILEX from BASF SE); (B1 .8) Bacillus subtilis strain GB03 (available as Kodiak® from Bayer AG, DE); (B1 .9) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina as the fungicide TAEGRO ® or TAEGRO ® ECO (EPA Registration No.
  • Bacillus mycoides, isolate J (available as BmJ TGAI or WG from Certis USA); (B1 .1 1) Bacillus licheniformis, in particular strain SB3086 (available as EcoGuard TM Biofungicide and Green Releaf from Novozymes); (B1 .12) a Paenibacillus sp. strain having Accession No. NRRL B-50972 or Accession No. NRRL B-67129 and described in International Patent Publication No. WO 2016/154297.
  • the biological control agent is a Bacillus subtilis or Bacillus amyloliquefaciens strain that produces a fengycin or plipastatin-type compound, an iturin-type compound, and/or a surfactin-type compound.
  • Bacillus subtilis or Bacillus amyloliquefaciens strain that produces a fengycin or plipastatin-type compound, an iturin-type compound, and/or a surfactin-type compound.
  • Bacillus strains capable of producing lipopeptides include Bacillus subtilis QST713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL Accession No. B21661 and described in U.S. Patent No. 6,060,051), Bacillus amyloliquefaciens strain D747 (available as Double NickelTM from Certis, US, having accession number FERM BP-8234 and disclosed in US Patent No. 7,094,592); Bacillus subtilis MBI600 (available as SUBTILEX ® from Becker Underwood, US EPA Reg. No.
  • Bacillus subtilis Y1336 (available as BIOBAC ® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos. 4764, 5454, 5096 and 5277); Bacillus amyloliquefaciens, in particular strain FZB42 (available as RHIZOVITAL ® from ABiTEP, DE); and Bacillus subtilis var. amyloliquefaciens FZB24 (available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina as the fungicide TAEGRO ® or TAEGRO ® ECO (EPA Registration No.
  • (B2) fungi for example: (B2.1) Coniothyrium minitans, in particular strain CON/M/91 -8 (Accession No. DSM-9660; e.g. Contans ® from Bayer); (B2.2) Metschnikowia fructicola, in particular strain NRRL Y- 30752 (e.g. Shemer®); (B2.3) Microsphaeropsis ochracea (e.g. Microx® from Prophyta); (B2.5) Trichoderma spp., including Trichoderma atroviride, strain SC1 described in International Application No.
  • Trichoderma atroviride from Kumiai Chemical Industry
  • Trichoderma atroviride strain CNCM 1-1237 (e.g. Esquive® WP from Agrauxine, FR);
  • Trichoderma atroviride strain no. V08/002387;
  • B2.40 Trichoderma atroviride, strain NMI no. V08/002388;
  • B2.41 Trichoderma atroviride, strain NMI no. V08/002389;
  • B2.42 Trichoderma atroviride, strain NMI no. V08/002390;
  • Trichoderma atroviride strain LC52 (e.g.
  • Trichoderma atroviride strain ATCC 20476 (IMI 206040); (B2.45) Trichoderma atroviride, strain T1 1 (IMI352941/ CECT20498); (B2.46) Trichoderma harmatum ⁇ (B2.47) Trichoderma harzianum ; (B2.48) Trichoderma harzianum rifai T39 (e.g. Trichodex® from Makhteshim, US); (B2.49) Trichoderma harzianum, in particular, strain KD (e.g.
  • Trichoplus from Biological Control Products, SA (acquired by Becker Underwood)); (B2.50) Trichoderma harzianum, strain ITEM 908 (e.g. Trianum-P from Koppert); (B2.51) Trichoderma harzianum, strain TH35 (e.g. Root-Pro by Mycontrol); (B2.52) Trichoderma virens (also known as Gliocladium virens), in particular strain GL-21 (e.g. SoilGard 12G by Certis, US); (B2.53) Trichoderma viride, strain TV1 (e.g. Trianum-P by Koppert); (B2.54) Ampelomyces quisqualis, in particular strain AQ 10 (e.g.
  • Botector® by bio-ferm, CH (B2.64) Cladosporium cladosporioides, strain H39 (by Stichting Divichting Diviching Diviching Diviching Diviching Diviching Divichoek); (B2.69) Gliocladium catenulatum (Synonym: Clonostachys rosea f. catenuiate) strain J1446 (e.g. Prestop ® by AgBio Inc. and also e.g. Primastop® by Kemira Agro Oy); (B2.70) Lecanicillium lecanii (formerly known as Verticillium lecanii ) conidia of strain KV01 (e.g.
  • Vertalec® by Koppert/Arysta (B2.71) PeniciIHum vermiculatum ⁇ , (B2.72) Pichia anomala, strain WRL-076 (NRRL Y-30842); (B2.75) Trichoderma atroviride, strain SKT-1 (FERM P-16510); (B2.76) Trichoderma atroviride, strain SKT-2 (FERM P-1651 1); (B2.77) Trichoderma atroviride, strain SKT-3 (FERM P-17021); (B2.78) Trichoderma gamsii (formerly T. viride), strain ICC080 (IMI CC 392151 CABI, e.g. BioDerma by AGROBIOSOL DE MEXICO, S.A.
  • Bacillus cereus in particular B. cereus strain CNCM 1-1562 and Bacillus firmus, strain 1-1582 (Accession number CNCM 1-1582), Bacillus subtilis strain OST 30002 (Accession No. NRRL B-50421), Bacillus thuringiensis, in particular B. thuringiensis subspecies israelensis (serotype H-14), strain AM65-52 (Accession No. ATCC 1276), B. thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372), B. thuringiensis subsp. kurstaki strain HD-1 , B. thuringiensis subsp.
  • fungi and yeasts selected from the group consisting of Beauveria bassiana, in particular strain ATCC 74040, Lecanicillium spp., in particular strain HRO LEC 12, Metarhizium anisopliae, in particular strain F52 (DSM3884 or ATCC 90448), Paecilomyces fumosoroseus (now: Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (Accesion No. ATCC 20874), and Paecilomyces lilacinus, in particular P. lilacinus strain 251 (AGAL 89/030550);
  • viruses selected from the group consisting of Adoxophyes orana (summer fruit tortrix) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, and Spodoptera littoralis (African cotton leafworm) NPV.
  • bacteria and fungi which can be added as 'inoculant' to plants or plant parts or plant organs and which, by virtue of their particular properties, promote plant growth and plant health.
  • Examples are: Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp., or Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suill
  • plant extracts and products formed by microorganisms including proteins and secondary metabolites which can be used as biological control agents such as Allium sativum, Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up ( Chenopodium quinoa saponin extract), Pyrethrum/Pyrethrins, Quassia amara, Quercus, Quillaja, Regalia, "RequiemTM Insecticide", rotenone, ryanial ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, Brassicaceae extract
  • insecticides examples include insecticides, acaricides and nematicides, respectively, which could be mixed with the compounds of formula (I) and compositions comprising thereof are:
  • Acetylcholinesterase (AChE) inhibitors such as, for example, carbamates, for example alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyr
  • GABA-gated chloride channel blockers such as, for example, cyclodiene-organochlorines, for example chlordane and endosulfan or phenylpyrazoles (fiproles), for example ethiprole and fipronil.
  • Sodium channel modulators such as, for example, pyrethroids, e.g. acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(I R)-trans-isomer], deltamethrin, empenthrin [(EZ)-(1 R)-i
  • Nicotinic acetylcholine receptor (nAChR) competitive modulators such as, for example, neonicotinoids, e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
  • neonicotinoids e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.
  • Nicotinic acetylcholine receptor (nAChR) allosteric modulators such as, for example, spinosyns, e.g. spinetoram and spinosad.
  • Glutamate-gated chloride channel (GluCI) allosteric modulators such as, for example, avermectins/milbemycins, for example abamectin, emamectin benzoate, lepimectin and milbemectin.
  • Juvenile hormone mimics such as, for example, juvenile hormone analogues, e.g. hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.
  • Miscellaneous non-specific (multi-site) inhibitors such as, for example, alkyl halides, e.g. methyl bromide and other alkyl halides; or chloropicrine or sulfuryl fluoride or borax or tartar emetic or methyl isocyanate generators, e.g. diazomet and metam.
  • alkyl halides e.g. methyl bromide and other alkyl halides
  • chloropicrine or sulfuryl fluoride or borax or tartar emetic or methyl isocyanate generators e.g. diazomet and metam.
  • Mite growth inhibitors such as, for example clofentezine, hexythiazox and diflovidazin or etoxazole.
  • Microbial disruptors of the insect gut membrane such as, for example Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis, and B.t. plant proteins: CrylAb, CrylAc, Cryl Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 /35Ab1 .
  • Inhibitors of mitochondrial ATP synthase such as, ATP disruptors such as, for example, diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatin oxide or propargite or tetradifon.
  • ATP disruptors such as, for example, diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatin oxide or propargite or tetradifon.
  • Nicotinic acetylcholine receptor channel blockers such as, for example, bensultap, cartap hydrochloride, thiocylam, and thiosultap-sodium.
  • Inhibitors of chitin biosynthesis type 0, such as, for example, bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.
  • Inhibitors of chitin biosynthesis type 1 , for example buprofezin.
  • Moulting disruptor in particular for Diptera, i.e. dipterans, such as, for example, cyromazine.
  • Ecdysone receptor agonists such as, for example, chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
  • Octopamine receptor agonists such as, for example, amitraz.
  • Mitochondrial complex III electron transport inhibitors such as, for example, hydramethylnone or acequinocyl or fluacrypyrim.
  • Mitochondrial complex I electron transport inhibitors such as, for example from the group of the METI acaricides, e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
  • METI acaricides e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenone (Derris).
  • Voltage-dependent sodium channel blockers such as, for example indoxacarb or metaflumizone.
  • Inhibitors of acetyl CoA carboxylase such as, for example, tetronic and tetramic acid derivatives, e.g. spirodiclofen, spiromesifen and spirotetramat.
  • Mitochondrial complex IV electron transport inhibitors such as, for example, phosphines, e.g. aluminium phosphide, calcium phosphide, phosphine and zinc phosphide or cyanides, e.g. calcium cyanide, potassium cyanide and sodium cyanide.
  • Mitochondrial complex II electron transport inhibitors such as, for example, befa-ketonitrile derivatives, e.g. cyenopyrafen and cyflumetofen and carboxanilides, such as, for example, pyflubumide.
  • Ryanodine receptor modulators such as, for example, diamides, e.g. chlorantraniliprole, cyantraniliprole and flubendiamide,
  • further active compounds such as, for example, Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate, Broflanilide, Bromopropylate, Chinomethionat, Chloroprallethrin, Cryolite, Cyclaniliprole, Cycloxaprid, Cyhalodiamide, Dicloromezotiaz, Dicofol, epsilon-Metofluthrin, epsilon- Momfluthrin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, kappa-Bifenthr
  • Examples of safeners which could be mixed with the compounds of formula (I) and compositions comprising thereof are, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-( ⁇ 4-[(methylcarbamoyl)amino]phenyl ⁇ - sulfonyl)benzamide (CAS 129531 -12-0), 4-(dichloroacetyl)-1 -oxa-4-azaspiro[4.5]decane (CAS 71526-07- 3), 2,2,5-trimethyl-3-(dichloroacetyl)-1 ,3
  • herbicides which could be mixed with the compounds of formula (I) and compositions comprising thereof are:
  • plant growth regulators are:
  • the compounds of formula (I) and the compositions comprising thereof have potent microbicidal activity. They can be used for controlling unwanted microorganisms, such as unwanted fungi and bacteria. They can be particularly useful in crop protection (they control microorganisms that cause plants diseases) or for protecting materials (e.g. industrial materials, timber, storage goods) as described in more details herein below. More specifically, the compounds of formula (I) and the compositions comprising thereof can be used to protect seeds, germinating seeds, emerged seedlings, plants, plant parts, fruits, harvest goods and/or the soil in which the plants grow from unwanted microorganisms.
  • Control or controlling as used herein encompasses protective, curative and eradicative treatment of unwanted microorganisms.
  • Unwanted microorganisms may be pathogenic bacteria, pathogenic virus, pathogenic oomycetes or pathogenic fungi, more specifically phytopathogenic bacteria phytopathogenic virus, phytopathogenic oomycetes or phytopathogenic fungi. As detailed herein below, these phytopathogenic microorganims are the causal agents of a broad spectrum of plants diseases.
  • the compounds of formula (I) and compositions comprising thereof can be used as fungicides.
  • the term“fungicide” refers to a compound or composition that can be used in crop protection for the control of unwanted fungi, such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes and/or for the control of Oomycetes, more preferably for the control of Basidiomycetes (causing rust diseases).
  • the present invention also relates to a method for controlling unwanted microorganisms, such as phytopathogenic fungi, oomycetes and bacteria, comprising the step of applying at least one compound of formula (I) or at least one composition comprising thereof to the microorganisms and/or their habitat (to the plants, plant parts, seeds, fruits or to the soil in which the plants grow).
  • unwanted microorganisms such as phytopathogenic fungi, oomycetes and bacteria
  • Suitable substrates that may be used for cultivating plants include inorganic based substrates, such as mineral wool, in particular stone wool, perlite, sand or gravel; organic substrates, such as peat, pine bark or sawdust; and petroleum based substrates such as polymeric foams or plastic beads.
  • Effective and plant-compatible amount means an amount that is sufficient to control or destroy the fungi present or liable to appear on the cropland and that does not entail any appreciable symptom of phytotoxicity for said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the crop growth stage, the climatic conditions and the respective compound or composition of the invention used. This amount can be determined by systematic field trials that are within the capabilities of a person skilled in the art.
  • the compounds of formula (I) and compositions comprising thereof may be applied to any plants or plant parts.
  • Plants mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the genetically modified plants (GMO ortransgenic plants) and the plant cultivars which are protectable and non-protectable by plant breeders’ rights.
  • Plant parts are understood to mean all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples of which include leaves, needles, stalks, stems, flowers, fruit bodies, fruits and seeds, and also roots, tubers and rhizomes.
  • the plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds.
  • Plants which may be treated in accordance with the methods of the invention include the following: cotton, flax, grapevine, fruit, vegetables, such as Rosaceae sp. (for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp.
  • Rosaceae sp. for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries
  • Rosaceae sp. for example pome fruits such as apples and pears, but also
  • Rubiaceae sp. for example coffee
  • Theaceae sp. Sterculiceae sp.
  • Rutaceae sp. for example lemons, oranges and grapefruit
  • Solanaceae sp. for example tomatoes
  • Liliaceae sp. for example lettuce
  • Umbelliferae sp. for example lettuce
  • Alliaceae sp. for example leek, onion
  • peas for example peas
  • major crop plants such as Gramineae sp. (for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example sunflower), Brassicaceae sp. (for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress), Fabacae sp. (for example bean, peanuts), Papilionaceae sp. (for example soya bean), Solanaceae sp. (for example potatoes), Chenopodiaceae sp. (for example sugar beet, fodder beet, swiss chard, beetroot); useful plants and ornamental plants for gardens and wooded areas; and genetically modified varieties of each of these plants.
  • wild plant species and plant cultivars or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and also parts thereof, are treated in accordance with the methods of the invention.
  • transgenic plants and plant cultivars obtained by genetic engineering methods if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated in accordance with the methods of the invention. More preferably, plants of the plant cultivars which are commercially available or are in use are treated in accordance with the invention.
  • Plant cultivars are understood to mean plants which have new properties ("traits") and have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes.
  • GMOs genetically modified organisms
  • Genetically modified plants are plants of which a heterologous gene has been stably integrated into genome.
  • the expression“heterologous gene” essentially means a gene which is provided or assembled outside the plant and when introduced in the nuclear, chloroplastic or mitochondrial genome gives the transformed plant new or improved agronomic or other properties by expressing a protein or polypeptide of interest or by down regulating or silencing other gene(s) which are present in the plant (using for example, antisense technology, cosuppression technology, RNA interference - RNAi - technology or microRNA - miRNA - technology).
  • a heterologous gene that is located in the genome is also called a transgene.
  • a transgene that is defined by its particular location in the plant genome is called a transformation or transgenic event.
  • Plants and plant cultivars which can be treated by the above disclosed methods include all plants which have genetic material which impart particularly advantageous, useful traits to these plants (whether obtained by breeding and/or biotechnological means).
  • Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids.
  • Plants and plant cultivars which can be treated by the above disclosed methods include those plants which are resistant to one or more abiotic stresses.
  • Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
  • Plants and plant cultivars which can be treated by the above disclosed methods include those plants characterized by enhanced yield characteristics. Increased yield in said plants can be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield can furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content and composition for example cotton or starch, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
  • Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stresses.
  • Plants and plant cultivars obtained by plant biotechnology methods such as genetic engineering
  • plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are herbicide- tolerant plants, i.e. plants made tolerant to one or more given herbicides.
  • Such plants can be obtained either by genetic transformation, or by selection of plants containing a mutation imparting such herbicide tolerance.
  • Plants and plant cultivars obtained by plant biotechnology methods such as genetic engineering
  • plants and plant cultivars which are insect-resistant transgenic plants i.e. plants made resistant to attack by certain target insects.
  • Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such insect resistance.
  • Plants and plant cultivars obtained by plant biotechnology methods such as genetic engineering
  • Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are tolerant to abiotic stresses.
  • Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such stress resistance.
  • Plants and plant cultivars obtained by plant biotechnology methods such as genetic engineering which can be treated by the above disclosed methods include plants and plant cultivars which show altered quantity, quality and/or storage-stability of the harvested product and/or altered properties of specific ingredients of the harvested product.
  • Plants and plant cultivars obtained by plant biotechnology methods such as genetic engineering which can be treated by the above disclosed methods include plants and plant cultivars, such as cotton plants, with altered fiber characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered fiber characteristics.
  • Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars, such as oilseed rape or related Brassica plants, with altered oil profile characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered oil profile characteristics. Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as oilseed rape or related Brassica plants, with altered seed shattering characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered seed shattering characteristics and include plants such as oilseed rape plants with delayed or reduced seed shattering. Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as Tobacco plants, with altered post-translational protein modification patterns.
  • phytopathogenic microorganisms such as phytopathogenic fungi, causing diseases, such as:
  • Blumeria species e.g. Blumeria graminis
  • Podosphaera species e.g. Podosphaera leucotricha
  • Sphaerotheca species e.g.Sphaerotheca fuliginea
  • Uncinula species e.g. Uncinula necator
  • Gymnosporangium species e.g. Gymnosporangium sabinae
  • Hemileia species e.g. Hemileia vastatrix
  • Phakopsora species e.g. Phakopsora pachyrhizi or Phakopsora meibomiae
  • Puccinia species e.g. Puccinia recondita, Puccinia graminis or Puccinia striiformis
  • Uromyces species e.g. Uromyces appendiculatus
  • Albugo species e.g. Albugo Candida
  • Bremia species e.g. Bremia lactucae
  • Peronospora species e.g. Peronospora pisi or P. brassicae
  • Phytophthora species e.g. Phytophthora infestans
  • Plasmopara species e.g. Plasmopara viticola
  • Pseudoperonospora species e.g. Pseudoperonospora humuli or Pseudoperonospora cubensis
  • Pythium species e.g. Pythium ultimum
  • Pythium species e.g. Pythium ultimum
  • leaf blotch diseases and leaf wilt diseases caused, for example, by Alternaria species (e.g. Alternaria solani), Cercospora species (e.g. Cercospora beticola), Cladiosporium species (e.g. Cladiosporium cucumerinum), Cochliobolus species (e.g. Cochliobolus sativus (conidial form: Drechslera, syn: Helminthosporium) or Cochliobolus miyabeanus), Colletotrichum species (e.g. Colletotrichum lindemuthanium), Cycloconium species (e.g. Cycloconium oleaginum), Diaporthe species (e.g.
  • Diaporthe citri Elsinoe species (e.g. Elsinoe fawcettii), Gloeosporium species (e.g. Gloeosporium laeticolor), Glomerella species (e.g. Glomerella cingulate), Guignardia species (e.g. Guignardia bidwelli), Leptosphaeria species (e.g. Leptosphaeria maculans), Magnaporthe species (e.g. Magnaporthe grisea), Microdochium species (e.g. Microdochium nivale), Mycosphaerella species (e.g.
  • Phaeosphaeria species e.g. Phaeosphaeria nodorum
  • Corticium species e.g. Corticium graminearum
  • Fusarium species e.g. Fusarium oxysporum
  • Gaeumannomyces species e.g. Gaeumannomyces graminis
  • Plasmodiophora species e.g. Plasmodiophora brassicae
  • Rhizoctonia species e.g. Rhizoctonia solani
  • Sarocladium species e.g. Sarocladium oryzae
  • Sclerotium species e.g. Sclerotium oryzae
  • Tapesia species e.g. Tapesia acuformis
  • Thielaviopsis species e.g.
  • Thielaviopsis basicola Thielaviopsis basicola
  • ear and panicle diseases caused, for example, by Alternaria species, (e.g. Alternaria spp.), Aspergillus species (e.g. Aspergillus flavus), Cladosporium species (e.g. Cladosporium cladosporioides, Claviceps species (e.g. Claviceps purpurea), Fusarium species, (e.g. Fusarium culmorum), Gibberella species (e.g. Gibberella zeae), Monographella species, (e.g. Monographella nivalis), Stagnospora species, (e.g. Stagnospora nodorum);
  • Alternaria species e.g. Alternaria spp.
  • Aspergillus species e.g. Aspergillus flavus
  • Cladosporium species e.g. Cladosporium cladospor
  • Sphacelotheca species e.g. Sphacelotheca reiliana
  • Tilletia species e.g. Tilletia caries or Tilletia controversa
  • Urocystis species e.g. Urocystis occulta
  • Ustilago species e.g. Ustilago nuda
  • fruit rot caused, for example, by Aspergillus species (e.g. Aspergillus flavus), Botrytis species (e.g. Botrytis cinerea), Penicillium species (e.g. Penicillium expansum or Penicillium purpurogenum), Rhizopus species (e.g. Rhizopus stolonifer), Sclerotinia species (e.g. Sclerotinia sclerotiorum), Verticilium species (e.g. Verticilium alboatrum) ;
  • Alternaria species e.g. Alternaria brassicicola
  • Aphanomyces species e.g. Aphanomyces euteiches
  • Ascochyta species e.g. Ascochyta lentis
  • Aspergillus species e.g. Aspergillus flavus
  • Cladosporium species e.g. Cladosporium herbarum
  • Cochliobolus species e.g. Cochliobolus sativus (conidial form: Drechslera, Bipolaris Syn: Helminthosporium)
  • Colletotrichum species e.g.
  • Fusarium species e.g. Fusarium culmorum
  • Gibberella species e.g. Gibberella zeae
  • Macrophomina species e.g. Macrophomina phaseolina
  • Microdochium species e.g. Microdochium nivale
  • Monographella species e.g. Monographella nivalis
  • Penicillium species e.g. Penicillium expansum
  • Phoma species e.g. Phoma lingam
  • Phomopsis species e.g. Phomopsis sojae
  • Phytophthora species e.g. Phytophthora cactorum
  • Pyrenophora species e.g.
  • Pyrenophora graminea Pyricularia species (e.g. Pyricularia oryzae), Pythium species (e.g. Pythium ultimum), Rhizoctonia species (e.g. Rhizoctonia solani), Rhizopus species (e.g. Rhizopus oryzae), Sclerotium species (e.g. Sclerotium rolfsii), Septoria species (e.g. Septoria nodorum), Typhula species (e.g. Typhula incarnate), Verticillium species (e.g. Verticillium dahlia);
  • Pyricularia species e.g. Pyricularia oryzae
  • Pythium species e.g. Pythium ultimum
  • Rhizoctonia species e.g. Rhizoctonia solani
  • Rhizopus species e.g. Rhizopus oryzae
  • Sclerotium species e.g. Sclerotium rolfsi
  • Nectria species e.g. Nectria galligena
  • Monilinia species e.g. Monilinia laxa
  • Exobasidium species e.g. Exobasidium vexans
  • Taphrina species e.g. Taphrina deformans
  • degenerative diseases in woody plants caused, for example, by Esca species (e.g. Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea), Ganoderma species (e.g. Ganoderma boninense);
  • Esca species e.g. Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea
  • Ganoderma species e.g. Ganoderma boninense
  • Botrytis species e.g. Botrytis cinerea
  • Rhizoctonia species e.g. Rhizoctonia solani
  • Helminthosporium species e.g. Helminthosporium solani
  • diseases caused by bacterial pathogens for example Xanthomonas species (e.g. Xanthomonas campestris pv. Oryzae), Pseudomonas species (e.g. Pseudomonas syringae pv. Lachrymans), Erwinia species (e.g. Erwinia amylovora).
  • the compounds of formula (I) and compositions comprising thereof are efficient in controlling pythopathogenic fungi causing rust diseases.
  • the method for controlling unwanted microorganisms may be used to protect seeds from phytopathogenic microorganisms, such as fungi.
  • seed(s) include dormant seed, primed seed, pregerminated seed and seed with emerged roots and leaves.
  • the present invention also relates to a method for protecting seeds and/or crops from unwanted microorganisms, such as bacteria or fungi, which comprises the step of treating the seeds with one or more compounds of formula (I) or a composition comprising thereof.
  • the treatment of seeds with the compound(s) of formula (I) or or a composition comprising thereof not only protects the seeds from phytopathogenic microorganisms, but also the germinating plants, the emerged seedlings and the plants after emergence.
  • the seeds treatment may be performed prior to sowing, at the time of sowing or shortly thereafter.
  • the seeds treatment may be performed as follows: the seeds may be placed into a mixer with a desired amount of compound(s) of formula (I) or a composition comprising thereof (either as such or after dilution), the seeds and the compound(s) of formula (I) or the composition comprising thereof are mixed until a homogeneous distribution on seeds is achieved. If appropriate, the seeds may then be dried.
  • the invention also relates to seeds treated with one or more compounds of formula (I) or a composition comprising thereof.
  • treated seeds allows not only protecting the seeds before and after sowing from unwanted microorganisms, such as phytopathogenic fungi, but also allows protecting the germinating plants and young seedlings emerging from said treated seeds.
  • a large part of the damage to crop plants caused by harmful organisms is triggered by the infection of the seeds before sowing or after germination of the plant. This phase is particularly critical since the roots and shoots of the growing plant are particularly sensitive, and even small damage may result in the death of the plant.
  • the present invention also relates to a method for protecting seeds, germinating plants and emerged seedlings, more generally to a method for protecting crop from phytopathogenic microorganisms, which comprises the step of using seeds treated by one or more compounds of formula (I) or a composition comprising thereof.
  • the seed is treated in a state in which it is sufficiently stable for no damage to occur in the course of treatment.
  • seeds can be treated at any time between harvest and shortly after sowing. It is customary to use seeds which have been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seeds which have been harvested, cleaned and dried down to a moisture content of less than 15% by weight.
  • seeds which, after drying for example, have been treated with water and then dried again, or seeds just after priming, or seeds stored in primed conditions or pre-germinated seeds, or seeds sown on nursery trays, tapes or paper.
  • the amount of compound(s) of formula (I) or composition comprising thereof applied to the seed is typically such that the germination of the seed is not impaired, or that the resulting plant is not damaged. This must be ensured particularly in case the active ingredients would exhibit phytotoxic effects at certain application rates.
  • the intrinsic phenotypes of transgenic plants should also be taken into consideration when determining the amount of compound(s) of formula (I) or composition comprising thereof to be applied to the seed in order to achieve optimum seed and germinating plant protection with a minimum amount of compound(s) of formula (I) or composition comprising thereof being employed.
  • the compounds of the formula (I) can be applied, as such, directly to the seeds, i.e. without the use of any other components and without having been diluted, or a composition comprising the compounds of formula (I) can be applied.
  • the compositions are applied to the seed in any suitable form.
  • suitable formulations include solutions, emulsions, suspensions, powders, foams, slurries or combined with other coating compositions for seed, such as film forming materials, pelleting materials, fine iron or other metal powders, granules, coating material for inactivated seeds, and also ULV formulations.
  • the formulations may be ready-to-use formulations or may be concentrates that need to be diluted prior to use.
  • formulations are prepared in a known manner, for instance by mixing the active ingredient or mixture thereof with customary additives, for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
  • customary additives for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
  • formulations are prepared in a known manner, by mixing the active ingredients or active ingredient combinations with customary additives, for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
  • customary additives for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
  • Useful dyes which may be present in the seed dressing formulations are all dyes which are customary for such purposes. It is possible to use either pigments, which are sparingly soluble in water, or dyes, which are soluble in water. Examples include the dyes known by the names Rhodamine B, C.l. Pigment Red 1 12 and C.l. Solvent Red 1 .
  • Useful wetting agents which may be present in the seed dressing formulations are all substances which promote wetting and which are conventionally used for the formulation of active agrochemical ingredients. Usable with preference are alkylnaphthalenesulfonates, such as diisopropyl- or diisobutylnaphthalenesulfonates.
  • Useful dispersants and/or emulsifiers which may be present in the seed dressing formulations are all nonionic, anionic and cationic dispersants conventionally used for the formulation of active agrochemical ingredients. Usable with preference are nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants.
  • Useful nonionic dispersants include especially ethylene oxide/propylene oxide block polymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ether, and the phosphated or sulfated derivatives thereof.
  • Suitable anionic dispersants are especially lignosulfonates, polyacrylic acid salts and arylsulfonate/formaldehyde condensates.
  • Antifoams which may be present in the seed dressing formulations are all foam-inhibiting substances conventionally used for the formulation of active agrochemical ingredients. Silicone antifoams and magnesium stearate can be used with preference.
  • Preservatives which may be present in the seed dressing formulations are all substances usable for such purposes in agrochemical compositions. Examples include dichlorophene and benzyl alcohol hemiformal.
  • Secondary thickeners which may be present in the seed dressing formulations are all substances usable for such purposes in agrochemical compositions. Preferred examples include cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica.
  • Adhesives which may be present in the seed dressing formulations are all customary binders usable in seed dressing products. Preferred examples include polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose.
  • the compounds of the formula (I) and the compositions comprising thereof are suitable for protecting seeds of any plant variety which is used in agriculture, in greenhouses, in forests or in horticulture. More particularly, the seed is that of cereals (such as wheat, barley, rye, millet, triticale, and oats), oilseed rape, maize, cotton, soybean, rice, potatoes, sunflower, beans, coffee, peas, beet (e.g. sugar beet and fodder beet), peanut, vegetables (such as tomato, cucumber, onions and lettuce), lawns and ornamental plants. Of particular significance is the treatment of the seed of wheat, soybean, oilseed rape, maize and rice.
  • the compounds of formula (I) or the compositions comprising thereof can be used for treating transgenic seeds, in particular seeds of plants capable of expressing a protein which acts against pests, herbicidal damage or abiotic stress, thereby increasing the protective effect. Synergistic effects may also occur in interaction with the substances formed by expression.
  • the compound of formula (I) can be applied as such, or for example in the form of as ready-to-use solutions, emulsions, water- or oil-based suspensions, powders, wettable powders, pastes, soluble powders, dusts, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural products impregnated with the compound of formula (I), synthetic substances impregnated with the compound of of formula (I), fertilizers or microencapsulations in polymeric substances.
  • Application is accomplished in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, spreading-on and the like. It is also possible to deploy the compound of formula (I) by the ultra-low volume method, via a drip irrigation system or drench application, to apply it in-furrow or to inject it into the soil stem or trunk. It is further possible to apply the compound of formula (I) by means of a wound seal, paint or other wound dressing.
  • the effective and plant-compatible amount of the compound of formula (I) which is applied to the plants, plant parts, fruits, seeds or soil will depend on various factors, such as the compound/composition employed, the subject of the treatment (plant, plant part, fruit, seed or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (curative and protective), the type of microorganisms, the development stage of the microorganisms, the sensitivity of the microorganisms, the crop growth stage and the environmental conditions.
  • the application rates can vary within a relatively wide range, depending on the kind of application.
  • the application rate may range from 0.1 to 10 000 g/ha, preferably from 10 to 1000 g/ha, more preferably from 50 to 300 g/ha (in the case of application by watering or dripping, it is even possible to reduce the application rate, especially when inert substrates such as rockwool or perlite are used).
  • the application rate may range from 0.1 to 200 g per 100 kg of seeds, preferably from 1 to 150 g per 100 kg of seeds, more preferably from 2.5 to 25 g per 100 kg of seeds, even more preferably from 2.5 to 12.5 g per 100 kg of seeds.
  • the application rate may range from 0.1 to 10 000 g/ha, preferably from 1 to 5000 g/ha.
  • the compound and the composition of the invention may also be used in the protection of materials, especially forthe protection of industrial materials against attack and destruction by unwanted microorganisms.
  • the compound and the composition of the invention may be used as antifouling compositions, alone or in combinations with other active ingredients.
  • Industrial materials in the present context are understood to mean inanimate materials which have been prepared for use in industry.
  • industrial materials which are to be protected from microbial alteration or destruction may be adhesives, glues, paper, wallpaper and board/cardboard, textiles, carpets, leather, wood, fibers and tissues, paints and plastic articles, cooling lubricants and other materials which can be infected with or destroyed by microorganisms.
  • Parts of production plants and buildings, for example cooling- water circuits, cooling and heating systems and ventilation and air-conditioning units, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected.
  • Industrial materials within the scope of the present invention preferably include adhesives, sizes, paper and card, leather, wood, paints, cooling lubricants and heat transfer fluids, more preferably wood.
  • the compound and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
  • the compound and the composition of the invention may also be used against fungal diseases liable to grow on or inside timber.
  • Timber means all types of species of wood, and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood, and plywood.
  • the compound and the composition of the invention may be used to protect objects which come into contact with saltwater or brackish water, especially hulls, screens, nets, buildings, moorings and signalling systems, from fouling.
  • Storage goods are understood to mean natural substances of vegetable or animal origin or processed products thereof which are of natural origin, and for which long-term protection is desired.
  • Storage goods of vegetable origin for example plants or plant parts, such as stems, leaves, tubers, seeds, fruits, grains, may be protected freshly harvested or after processing by (pre)drying, moistening, comminuting, grinding, pressing or roasting.
  • Storage goods also include timber, both unprocessed, such as construction timber, electricity poles and barriers, or in the form of finished products, such as furniture.
  • Storage goods of animal origin are, for example, hides, leather, furs and hairs.
  • the compound and the composition of the invention may prevent adverse effects, such as rotting, decay, discoloration, decoloration or formation of mould.
  • Microorganisms capable of degrading or altering industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms.
  • the compound and the composition of the invention preferably act against fungi, especially moulds, wood-discoloring and wood-destroying fungi ( Ascomycetes , Basidiomycetes, Deuteromycetes and Zygomycetes), and against slime organisms and algae.
  • microorganisms of the following genera Alternaria, such as Altemaria tenuis Aspergillus, such as Aspergillus niger, Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana Lentinus, such as Lentinus tigrinus ; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor, Aureobasidium, such as Aureobasidium pullulans ; Sclerophoma, such as Sclerophoma pityophila ; Trichoderma, such as Trichoderma viride Ophiostoma spp., Ceratocystis spp., Humicola spp., Petriella spp., Trichurus spp., Coriolus spp., Gloeophyllum spp., Pleurotus spp., Poria
  • LogP value is determined by measurement of LC-UV, in an acidic range, with 0.1 % formic acid in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • [bl LogP value is determined by measurement of LC-UV, in a neutral range, with 0.001 molar ammonium acetate solution in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • [cl LogP value is determined by measurement of LC-UV, in an acidic range, with 0.1 % phosphoric acid and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).
  • 1 H-NMR data of selected examples as provided herein are written in form of 1 H-NMR-peak lists. To each signal peak are listed the d-value in ppm and the signal intensity in round brackets. Between the 5-value - signal intensity pairs are semicolons as delimiters.
  • Intensity of sharp signals correlates with the height of the signals in a printed example of a NMR spectrum in cm and shows the real relations of signal intensities. From broad signals several peaks or the middle of the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown.
  • tetramethylsilane For calibrating chemical shift for 1 H spectra, we use tetramethylsilane and/or the chemical shift of the solvent used, especially in the case of spectra measured in DMSO. Therefore in NMR peak lists, tetramethylsilane peak can occur but not necessarily.
  • the 1 H-NMR peak lists are similar to classical 1 H-NMR prints and contains therefore usually all peaks, which are listed at classical NMR-interpretation. Additionally they can show like classical 1 H-NMR prints signals of solvents, stereoisomers of the target compounds, which are also object of the invention, and/or peaks of impurities.
  • the peaks of stereoisomers of the target compounds and/or peaks of impurities have usually on average a lower intensity than the peaks of target compounds (for example with a purity >90%).
  • Such stereoisomers and/or impurities can be typical for the specific preparation process. Therefore their peaks can help to recognize the reproduction of our preparation process via“side-products-fingerprints”.
  • An expert who calculates the peaks of the target compounds with known methods (MestreC, ACD- simulation, but also with empirically evaluated expectation values) can isolate the peaks of the target compounds as needed optionally using additional intensity filters. This isolation would be similar to relevant peak picking at classical 1 H-NMR interpretation.
  • Table 1 illustrates in a non-limiting manner examples of compounds of formula (I) according to the invention:
  • Table 2 provides the NMR data ( 1 H) of a selected number of compounds from table 1.
  • Example A in vitro cell test on Colletothchum Hndemuthianum
  • Inoculum spore suspension
  • the tested compounds were solubilized in dimethyl sulfoxide and the solution used to prepare the required range of concentrations.
  • the final concentration of dimethyl sulfoxide used in the assay was ⁇ 1 %.
  • a spore suspension of Colletothchum Hndemuthianum was prepared and diluted to the desired spore density.
  • the compounds were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay.
  • the compounds were added in the desired concentration to the culture medium with spores. After 6 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the tested compounds with the absorbance in control wells without tested compounds.
  • Example B in vitro cell test on Pyricularia orvzae
  • Inoculum spore suspension
  • the tested compounds were solubilized in dimethyl sulfoxide and the solution used to prepare the required range of concentrations.
  • the final concentration of dimethyl sulfoxide used in the assay was ⁇ 1 %.
  • a spore suspension of Pyricularia oryzae was prepared and diluted to the desired spore density.
  • the compounds were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay.
  • the compounds were added in the desired concentration to the culture medium with spores. After 5 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the tested compounds with the absorbance in control wells without tested compounds.
  • the following compounds according to the invention showed efficacy between 80% and 89% at a concentration of 20 ppm of active ingredient: 1.010; 1.041 ; 1.068; 1.091 ; 1.101 ; 1.108.
  • the following compounds according to the invention showed efficacy between 90% and 100% at a concentration of 20 ppm of active ingredient: 1.004; 1.005; 1.006; 1.015; 1.016; 1.019; 1.020; 1.021 ; 1.022; 1.025; 1.028; 1.043; 1.048; I.049; I.050; 1.054; 1.055; I.057; I.065; 1.066; 1.067; 1.070; I.074; I.075; I.076; 1.080; 1.082; 1.086; 1.087; I.088; I.094; 1.100; 1.1 1 1 .
  • Example C in vitro cell test on Rhizoctonia solani
  • Inoculum spore suspension
  • the tested compounds were solubilized in dimethyl sulfoxide and the solution used to prepare the required range of concentrations.
  • the final concentration of dimethyl sulfoxide used in the assay was ⁇ 1 %.
  • Inoculum was prepared from a pre-culture of Rhizoctonia solani grown in liquid medium by homogenization using a blender. The concentration of ground mycelium in the inoculum was estimated and adjusted to the desired optical density (OD).
  • the compounds were evaluated for their ability to inhibit mycelium growth in liquid culture assay.
  • the compounds were added in the desired concentrations to culture medium containing the mycelial suspension. After 5 days of incubation, the fungicidal efficacy of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the tested compounds with the absorbance in control wells without thetested compounds.
  • Emulsifier 1 pL of Tween® 80 per mg of active ingredient
  • the tested compounds were made soluble and homogenized in a mixture of dimethyl sulfoxide/acetone/ /Tween® 80 and then diluted in water to the desired concentration.
  • the young plants of wheat were treated by spraying the tested compound prepared as described above. Control plants were treated only with an aqueous solution of acetone/dimethyl sulfoxide/ Tween® 80. After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Puccinia recondite spores. The contaminated wheat plants were incubated for 24 hours at 20 °C and at 100% relative humidity and then for 9 days at 20 °C and at 70-80% relative humidity.
  • the test was evaluated 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
  • Example E in vivo preventive test on Phakopsora pachyrhizi (soybeans ' )
  • Emulsifier 1 pL of Tween® 80 per mg of active ingredient
  • the tested compounds were made soluble and homogenized in a mixture of dimethyl sulfoxide/acetone/ /Tween® 80 and then diluted in water to the desired concentration.
  • the young plants of soybean were treated by spraying the tested compound prepared as described above. Control plants were treated only with an aqueous solution of acetone/dimethyl sulfoxide/ Tween® 80.
  • the plants were contaminated by spraying the leaves with an aqueous suspension of Phakospora pachyrhizi spores.
  • the contaminated soybean plants were incubated for 24 hours at 24 °C and at 100% relative humidity and then for 10 days at 24 °C and at 70-80% relative humidity.
  • the test was evaluated 1 1 days after the inoculation. 0% means an efficacy which corresponds to that of the control plants while an efficacy of 100% means that no disease was observed.
  • the following compounds according to the invention showed efficacy between 70% and 79% at a concentration of 250 ppm of active ingredient: 1.009; 1.018; 1.044; 1.062; 1.076; 1.105.
  • Emulsifier 1 part by weight of polyoxyethylene sorbitan monooleate
  • the plants remained in the incubation cabinet at approximately 24 °C and a relative atmospheric humidity of approximately 80% and a day / night interval of 12h.
  • Emulsifier 1 part by weight of polyoxyethylene sorbitan monooleate
  • the plants remained in the incubation cabinet at approximately 24 °C and a relative atmospheric humidity of approximately 80 % and a day / night interval of 12h.
  • Emulsifier 1 part by weight of polyoxyethylene sorbitan monooleate
  • the plants remained in the incubation cabinet at approximately 24 °C and a relative atmospheric humidity of approximately 80% and a day / night interval of 12h.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention concerne de nouveaux dérivés d'hydroxyisoxazolines, leur utilisation en tant que fongicides et des compositions les comprenant. Formule (I)
EP20734145.4A 2019-06-21 2020-06-18 Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques Withdrawn EP3986874A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19181803 2019-06-21
PCT/EP2020/066935 WO2020254489A1 (fr) 2019-06-21 2020-06-18 Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques

Publications (1)

Publication Number Publication Date
EP3986874A1 true EP3986874A1 (fr) 2022-04-27

Family

ID=67001699

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20734145.4A Withdrawn EP3986874A1 (fr) 2019-06-21 2020-06-18 Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques

Country Status (6)

Country Link
EP (1) EP3986874A1 (fr)
AR (1) AR119216A1 (fr)
BR (1) BR112021025333A2 (fr)
TW (1) TW202115001A (fr)
UY (1) UY38760A (fr)
WO (1) WO2020254489A1 (fr)

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
PT981540E (pt) 1997-05-09 2006-09-29 Agraquest Inc Nova estripe de bacillus para controlo de doencas de plantas e lagarta da raiz do milho
EP0998468A1 (fr) 1997-07-23 2000-05-10 Basf Aktiengesellschaft 3-phenylisoxazoline substituee
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
JP4071036B2 (ja) 2001-11-26 2008-04-02 クミアイ化学工業株式会社 バシルスｓｐ．Ｄ７４７菌株およびそれを用いた植物病害防除剤および害虫防除剤
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
RU2392273C2 (ru) 2004-09-10 2010-06-20 Синджента Лимитед Замещенные изоксазолы в качестве фунгицидов
MX2007004710A (es) 2004-10-20 2007-06-14 Kumiai Chemical Industry Co Derivado de sulfuro de 3-triazolilfenilo e insecticida/acaricida/ nematicida que contiene el mismo como ingrediente activo.
EA014057B1 (ru) 2005-10-06 2010-08-30 Ниппон Сода Ко., Лтд. Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями
EP1878730A1 (fr) * 2006-07-12 2008-01-16 Bayer Schering Pharma Aktiengesellschaft Isoxazolines substituées, compositions pharmaceutiques les comprenant, procédés pour leur préparation et leur usage
JP5268461B2 (ja) 2008-07-14 2013-08-21 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Ｐｆ１３６４物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (fr) 2008-11-05 2010-05-12 Bayer CropScience AG Composés substitués par l'halogène comme pesticides
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
CA2746394C (fr) 2008-12-12 2017-08-29 Syngenta Limited N-oxypiperidines spiroheterocycliques utilisees comme pesticides
WO2011085575A1 (fr) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Composés de formanilide hétérocyclique, leurs procédés de synthèse et leur utilisation
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
US20140018242A1 (en) 2010-05-31 2014-01-16 Syngenta Participations Ag Method of crop enhancement
EP2959775A1 (fr) 2010-08-31 2015-12-30 Meiji Seika Pharma Co., Ltd. Agents de contrôle de nuisibles
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
WO2013050317A1 (fr) 2011-10-03 2013-04-11 Syngenta Limited Formes polymorphes d'un dérivé d'isoxazoline
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
US9334238B2 (en) 2012-03-30 2016-05-10 Basf Se N-substituted pyridinylidenes for combating animal pests
EP2647626A1 (fr) 2012-04-03 2013-10-09 Syngenta Participations AG. Dérivés de 1-aza-spiro[4.5]déc-3-ène and 1,8-diaza-spiro[4.5]déc-3-ène en tant que pesticides
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
BR112014026746A2 (pt) 2012-04-27 2017-06-27 Dow Agrosciences Llc composições pesticidas e processos relacionados com as mesmas
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
BR112015029268B1 (pt) 2013-05-23 2020-10-20 Syngenta Participations Ag composição pesticida, pacote de combinação, utilização, método de aumento da eficácia e redução da fitotoxicidade de compostos de ácido tetrâmico ativos em termos pesticidas, método não terapêutico para combater e controlar pragas
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
MX2016004942A (es) 2013-10-17 2016-06-28 Dow Agrosciences Llc Procesos para la preparacion de compuestos plaguicidas.
JP2017078022A (ja) 2014-02-28 2017-04-27 クミアイ化学工業株式会社 イソキサゾール誘導体及びそれを用いた農園芸用植物病害防除剤
TW201613866A (en) 2014-07-07 2016-04-16 Bayer Cropscience Ag Process for preparing fluorinated iminopyridine compounds
KR101961581B1 (ko) 2015-02-17 2019-03-22 닛뽕소다 가부시키가이샤 농약 조성물
JP6916737B2 (ja) 2015-03-26 2021-08-11 バイエル クロップサイエンス エルピーＢａｙｅｒ Ｃｒｏｐｓｃｉｅｎｃｅ Ｌｐ 新規なパエニバチルス（ｐａｅｎｉｂａｃｉｌｌｕｓ）株、抗真菌化合物、およびそれらの使用のための方法
CN107588290B (zh) 2016-07-08 2020-05-22 青岛海尔洗衣机有限公司 一种家用电器
CN110621669A (zh) 2017-05-04 2019-12-27 巴斯夫欧洲公司 防除植物病原性真菌的取代5-卤代烷基-5-羟基异噁唑类
WO2019122393A1 (fr) 2017-12-22 2019-06-27 Bayer Aktiengesellschaft Hydroxyisoxazolines et leurs dérivés

Also Published As

Publication number Publication date
BR112021025333A2 (pt) 2022-05-24
WO2020254489A1 (fr) 2020-12-24
TW202115001A (zh) 2021-04-16
UY38760A (es) 2021-01-29
AR119216A1 (es) 2021-12-01

Similar Documents

Publication Publication Date Title
EP3897154A1 (fr) 1,3,4-oxadiazoles et leurs dérivés en tant que nouveaux agents antifongiques
AU2019252328A1 (en) Oxadiazoline derivatives
WO2021249995A1 (fr) Hétérocycles à substitution azabicyclyle utilisés comme fongicides
WO2022129190A1 (fr) 1,2,4-oxadiazoles substitués par (hétéro)aryle utilisés comme fongicides
WO2021255070A1 (fr) Combinaisons de composés actifs
WO2021228734A1 (fr) (thio)amides de triazine et de pyrimidine utilisés comme composés fongicides
EP4161906A1 (fr) Hétérocyclyl pyrimidines et triazines en tant que nouveaux fongicides
WO2020182929A1 (fr) Urées et dérivés substitués en tant que nouveaux agents antifongiques
WO2021239766A1 (fr) Combinaisons de composés actifs
WO2021255091A1 (fr) 1,3,4-oxadiazoles et leurs dérivés comme fongicides
EP4077302A1 (fr) Thiophène carboxamides substitués, acides thiophène carboxyliques et leurs dérivés
EP4077303B1 (fr) Thiophene carboxamides substitues et ses dérivés comme des agents microbiocides
WO2021255089A1 (fr) 1,3,4-oxadiazole pyrimidines et 1,3,4-oxadiazole pyridines utilisées comme fongicides
WO2021255170A1 (fr) 1,3,4-oxadiazole pyrimidines en tant que fongicides
AU2020404123A1 (en) Substituted thiophene carboxamides and derivatives thereof
EP3986874A1 (fr) Benzylphényl hydroxyisoxazolines et analogues en tant que nouveaux agents antifongiques
WO2020254490A1 (fr) Phénoxyphényl hydroxyisoxazolines et analogues utilisés en tant que nouveaux agents antifongiques
WO2021255169A1 (fr) 1,3,4-oxadiazole pyrimidines en tant que fongicides
WO2022129188A1 (fr) 1,2,4-oxadiazol-3-yl pyrimidines en tant que fongicides
WO2022058327A1 (fr) Urées et dérivés substitués en tant que nouveaux agents antifongiques
WO2022129196A1 (fr) 1,2,4-oxadiazoles substitués par hétérobicycle utilisés en tant que fongicides

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220121

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230222

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230705